Combination of optical coherence tomography and Raman spectroscopy by Egodage, Kokila Dampali
Combination of optical coherence tomography 
and Raman spectroscopy 
 
 
Dissertation 
zur Erlangung des akademischen Grades doctor rerum naturalium 
(Dr. rer. nat.) 
 
 
 
 
 
 
vorgelegt dem Rat der Chemisch-Geowissenschaftlichen Fakultät der 
Friedrich-Schiller-Universität Jena 
von Kokila Dampali Egodage 
geboren am 23.04.1988 in Galle, Sri Lanka 
 i 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gutachter: 
1. Prof. Dr. Jürgen Popp, Institut für Physikalische Chemie, FSU Jena 
2. Prof. Dr. Volker Deckert, Institut für Physikalische Chemie, FSU Jena 
 
Tag der Verteidigung: 27. Juni 2018 
Table of contents ii 
Table of Contents 
List of abbreviations ................................................................................................. iv 
Acknowledgements ..................................................................................................... v 
1 Introduction .......................................................................................................... 7 
1.1 Outline of thesis ............................................................................................... 11 
2 Theory ................................................................................................................ 13 
2.1 Optical coherence tomography ........................................................................ 13 
2.2 Raman spectroscopy ........................................................................................ 16 
3 Material and methods ........................................................................................ 18 
3.1 OCT-Raman combination for clinical application ....................................... 18 
3.2 Device implementation ................................................................................ 20 
3.3 Scanning system .......................................................................................... 22 
3.4 Dichroic mirrors and alignment procedure .................................................. 23 
3.5 The Raman spectrometer and SD-OCT system .......................................... 25 
3.6 Objective lens .............................................................................................. 27 
3.7 Integration into the medical cart ................................................................ 28 
3.8 System characterization ............................................................................... 31 
3.8.1 Measuring system resolution ................................................................. 31 
3.8.2 The choice of objective lens .................................................................. 33 
3.8.3 Application on biological tissue ............................................................ 34 
3.8.4 Preliminary measurements on pork skin ............................................... 37 
4 Results and discussion ........................................................................................ 40 
4.1 A pilot clinical study ................................................................................... 40 
4.2 Investigating atherosclerotic plaques ........................................................... 50 
4.2.1 Evidence before the combination. ......................................................... 50 
4.2.2 Combined OCT-Raman system measurements ex vivo human aorta .. 54 
4.2.3 In vivo plaque investigation .................................................................. 57 
5 Fiber approach ....................................................................................................... 66 
5.1 Sample holder .............................................................................................. 66 
5.2 Needle probe ................................................................................................ 67 
5.3 SS-OCT fiber system ................................................................................... 69 
5.4 Application of the OCT needle probe on ex vivo rabbit aorta .................... 71 
6 Summary ............................................................................................................ 75 
Zusammenfassung ..................................................................................................... vi 
Table of contents iii 
Statement of authorship ............................................................................................ xi 
References ............................................................................................................... xiii 
 
 
List of abbreviations iv 
List of abbreviations 
AR   anti-reflective 
BCC    basal cell carcinoma 
CARS  coherent anti-stokes Raman spectroscopy 
CVD    cardiovascular disease 
EvG  elastic van Gieson 
FLIM   fluorescence lifetime imaging 
FOV    field of view 
GRIN   gradient index 
H&E  hematoxylin and eosin 
IVUS    intravascular ultrasound 
MM  multimode 
NCF    no-core fiber 
NIRS    near infrared spectroscopy 
OCT    optical coherence tomography 
SCC   squamous cell carcinoma 
SD   spectral domain 
SHG  second harmonic generation 
SMF    single mode fiber 
SNR    signal-to-noise ratio 
SS    swept source 
TD    time domain 
TPEF  two-photon excitation microscopy 
Acknowledgements  v 
Acknowledgements 
First, I would like to thank Carl Zeiss for funding this project and allowing me to 
accomplish this challenging adventure. My sincere gratitude goes to Dr. Sebastian 
Dochow and Dr. Christian Matthäus for taking me under their wings, training me 
throughout my PhD and preparing me for the big bad world. You two have provided 
me with knowledge, lots of courage and motivation in the past three or so years. 
Immense gratitude also goes to apl. Prof. Schmitt and Prof. Popp for being the strong 
pillars of the institute where all the scientific magic happens. In my first year I was 
working at Dr. Christoph Krafft’s laboratory and I am very thankful for this time as 
I was able to work with Dr. Sara Piqueras from Spain with whom I now share a 
publication.  
 
My loving parents, thank you for supporting and allowing me to go on this journey 
(with so much hesitation) and keeping up with my stressful and unstable lifestyle. 
Thank you for being strong and always helping me when I am knee deep in trouble. 
I cannot repay you enough for everything you have sacrificed for me. 
 
My dear fellow office mates: Jan and Roman (my heroes in R), Katharinchen, Iwan, 
Clärchen (thank you for the corrections), Tania and Mohamed. Thank you enough 
for being supportive and making even the tough times pass-on like a breeze. Our 
group fun times and Christmas parties were the best! I am sure I will never find an 
amazing working group as you all. I am going to miss you dearly.  
 
Friedrich, thank you for motivating me and saying everything will be OK. Thank you 
for believing in me, having faith and for not giving up on me. Thank you for training 
my German language skills and giving me confidence to speak it. You reminded me 
of myself when I was young, ambitious and wanting to reach the stars. That reminder 
helped me get through this chapter of my life.  
 
Finally, I would like to list some of those who have helped me by even a teeny tiny 
bit: Michael Hermes, Marcel Dahms, Stefan Hanf, Andreas Hänsel, Albrecht, Michael 
Teupser, Martin, Per-Christian Heisel, Christian Karass, Alexandar Lukic, Anuradha 
Ramoji, Antje Raabe, Marion Krause, Annett Bodien, Dorit Schmidt, Mario 
Kindermann, Martina Hampel and Benita Göbel. The blue overall crew (Detlef, 
Georg, Robert and etc.) should not be forgotten as they would always come to my 
rescue whenever I needed help. Those outside campus who had been my emotional 
support include Ajay, Bjoern, Pascal and Jeremy, thank you for the companionship 
over the years. Of course, Hina Nisar, my best friend since high school, have been 
supporting me from far far away through prayers and words at all times.  
Acknowledgements  vi 
To conclude, I am very grateful for being able to complete my doctoral project in 
Jena, Germany, as I have had very many memorable experiences that have allowed 
me to be the person I am now.  
 
 
 
CHAPTER 1 Introduction 7 
1 Introduction 
Medical devices have evolved dramatically since the introduction of X-ray imaging 
into routine hospital procedures. This trend was a result of the essential need to 
screen for diseases that are located deep within the body. Nowadays, endoscopes are 
being widely used to provide prognostic information followed by targeted therapeutics 
increasing patient recovery rates [1, 2]. Therefore, novel medical device development 
is generally heading towards providing an accurate and early in vivo diagnosis at a 
faster rate, with no or minimal invasiveness. Many efforts are being promoted to 
produce devices to fulfill these standards, especially to diagnose diseases with a 
strategic advantage i.e. those tending towards increased recovery rates upon early 
diagnosis. Diseases such as cancer and atherosclerosis fall into this category. It has 
been shown that early diagnosis and targeted medication, either surgical or 
therapeutic, increase the chances of recovery significantly. The importance of early 
diagnosis has been observed, for example, by the 70% reduction in mortality in 
cervical cancer since the introduction of the Pap smear screening test [3]. Many early 
screening programs for a wide range of diseases have been implemented to promote 
early detection as the chance of recovery decreases drastically along with disease 
progression. This is very well observed with cancer which has become the second 
leading cause of death in the United States alone, and it has been estimated that in 
the year 2030 the numbers will increase to 13 million worldwide with 21.7 million 
new cases [4]. The main cause of cancer is still subject to speculation where specific 
mutations, exposure to the sun and modern lifestyle are only a few probable causes. 
These internal and external factors can induce cells to proliferate at an abnormal rate 
thereby producing a necrotic cell mass at the core that continues its growth unless 
intervened. This manifestation is termed as a ‘tumor’ and if the proliferation becomes 
aggressive, these cells would reach the blood stream and spread through the organism 
resulting in metastasis (malignant) whereas benign cancers are mostly confined to 
certain regions. Lack of care or neglect, however, would dramatically decrease the 
chances of recovery resulting in eventual death [4]. 
 
Similar to cancer, modern lifestyle and aging are well-known causes of atherosclerosis 
which is one of the cardiovascular diseases (CVD) that takes more than 17 million 
lives each year globally [5]. Due to damage or inflammation, arterial endothelium 
membranes can become susceptible to deposition and permeation of various lipids 
circulating through the bloodstream such as cholesterol and cholesterol ester. At the 
onset of this process, monocytes, a type of white blood cells, become attracted to and 
move into the arterial membrane. There, they differentiate into macrophages, taking 
up lipids and other cellular debris. Macrophages play an important role in lipid 
decomposition within tissue but can be overwhelmed by toxic lipid levels in the blood 
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stream causing metabolic stress, subsequent cell death and the accumulation of 
cellular debris, which produce arterial swelling. This localized effect results in a lipid-
rich plaque that eventually may cause a state of atherothrombosis leading to fatal 
consequences such as myocardial infarction or stroke. The biochemical composition 
of arterial plaques can vary [6] and it is well known that the severity of a plaque and 
its stability are strongly correlated with its biochemical composition [7]. Despite the 
long-term prevalence of CVDs, the identification of vulnerable plaques remains one 
of the most important and challenging aspects in cardiology. There are several types 
of vulnerable plaques with distinct biochemical compositions. For example, most 
common characteristics range within complex lipid cores, thin fibrous caps infiltrated 
by macrophages, proteo-glycan matrices in a smooth muscle cell-rich environment, 
intra-plaque hemorrhage and calcific nodules invading the arterial lumen [8]. Hence, 
having specific biochemical information of plaque composition would greatly improve 
the risk assessment and management of atherosclerosis.  
 
MOTIVATION 
 
The current ‘gold standard’ for cancer diagnosis is via microscopic imaging of stained 
tissue slices. This routine sample extracting procedure consists of a tissue biopsy 
performed by a surgeon and the difficulty in this procedure depends strongly on the 
tumor location. For example, tumors of internal organs lead to complicated and 
painful surgical procedures in which all efforts would be eventually dedicated to 
diagnosis. The biopsied sample is then sectioned and stained most commonly by 
hematoxylin and eosin (H&E) to reveal subcellular features where a histopathologic 
diagnosis is conducted by a well-trained individual (pathologist) to identify the type 
and stage of tumor. This procedure is well known to have false positives and long 
waiting times that heavily affect the standard of patient care [9, 10]. If the biopsy 
results show signs of a tumor, appropriate intervening steps would be taken, 
depending on the stage of disease progression. In the case of the former, the patient 
maybe called for another biopsy, resulting in higher costs and expenditures. This can 
be avoided all together with the routine utilization of efficient and specific diagnostic 
tools.  
 
The term ‘optical biopsy’ in disease inspection was coined as an alternative method 
to tissue biopsy where light and its properties are used to produce cross-sectional 
images of biological matter. This was an outcome from a field of life science known 
as biophotonics, which uses optical and spectroscopic methods to characterize diseases 
at a molecular level either by high-resolution imaging or identifying biomarkers [11]. 
Clinically incorporated imaging methods, such as computed tomography (CT), 
magnetic resonance imaging (MRI) and ultrasound imaging, fulfill the criteria of 
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obtaining non-invasive cross-sectional images of tissue [12]. Even though these 
techniques are readily used to obtain detailed images from hard-to-access regions such 
as the cranial cavity, they have disadvantages due to their basic working principles. 
For example, CT scans require a contrast agent to achieve better imaging quality due 
to the applied X-ray radiation, which in fact can be harmful to the patient. Despite 
its high resolution, CT scanning devices are bulky, a property shared with MRI. 
Based on magnetic fields, the latter also requires contrast agents and is very costly. 
Ultrasound exceeds all aforementioned disadvantages but lacks high-resolution 
capability. Thus, a niche for an imaging technique exists that must be compact, 
inexpensive and produces high resolution images. After the large interest in the field 
of ophthalmology in recent years, optical coherence tomography (OCT) seems to fill 
this space suitably [13]. It is based on interferometric imaging that utilizes coherent 
property of light to image subsurface morphology. Since then, OCT has been used in 
many biomedical applications and has been readily used in some countries as an 
optical guidance in cardiac surgeries such as bypass and stent implants [14]. In 
addition, there has been experimental work done on identifying non- melanoma and 
pre-cancers in vivo [15, 16]. The suitability of OCT for detecting skin cancers had 
been confirmed by the successful correlation of cross-sectional OCT images of basal 
cell carcinoma (BCC) with histopathologic data [17-20]. Detailed information on 
tumor morphology with a spatial resolution in the order of 10- 15 µm and a 
penetration depth of 1- 2 mm in skin have been reported [21-23]. This method would 
be able to extract more information as opposed to dermoscopy that has been widely 
used as a screening method. It provides the color and minimal microstructural 
features that would require well trained personnel for a subjective diagnosis [24]. 
 
A technique complementary to cross-sectional imaging would be a method that 
provides specific chemical information that identifies the molecular ‘fingerprint’ of 
the substance under investigation. Extensive research has been conducted especially 
in the field of fluorescence as well as infrared spectroscopy that has shown the 
feasibility of applying analytical methods to differentiate between diseased and 
healthy tissue [25, 26]. The application of optical spectroscopic methods primarily in 
biology and medicine was due to the large matrix of molecular combinations that 
require high chemical specificity and thus a need for a method that provides 
consistent data [27]. Raman spectroscopy is suitable for this application as it enables 
accurate and specific molecular identification. It has also been widely used in 
numerous disease recognition studies that have gained acceptance as a powerful 
histopathologic tool especially in optical biopsies [28, 29]. A large variety of cancer 
types have been analyzed using Raman spectroscopy [30-32] but the only drawback 
of this technique in biomedical application is its low sensitivity which results in large 
measuring or integration times.  
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Therefore, as a proposed solution, a combination of OCT and Raman spectroscopy is 
presented followed by the outcome of its application in characterizing non-melanoma 
skin cancers as well as atherosclerotic plaques. This effort required a novel biomedical 
device applicable in diagnostic routines, capable of imaging as well as obtaining 
chemical information. Thus, two modalities were included where one captures depth 
information in the form of a real-time image and the other provides spectroscopic 
data from desired regions with high biochemical specificity. Pioneered by the group 
of Anita Mahadevan-Jansen, a combination of OCT and Raman spectroscopy had 
been used to investigate in vivo non-melanoma skin cancers [33-35]. Other groups 
have applied the same concept for inspecting ex vivo porcine retinas [36] and psoriasis 
[36, 37].  
 
The second type of disease in question is atherosclerosis and the associated plaques 
have been investigated in vivo via imaging techniques such as intravascular 
ultrasound (IVUS), CT and OCT [38, 39]. It is a challenge to obtain reliable 
information about the stage and type of plaques accurately with imaging methods 
purely. Most vital changes that occur are within their chemical composition and 
topology. With more advanced plaques, a fibrous thin cap has been commonly 
observed that would cover the lipid-rich core which becomes highly unstable and, on 
sudden rupture, causes a cardiac event. The current clinical diagnostic routine 
involves echocardiography and angiography to pinpoint blocked arteries. Most 
commonly, urgent cases are treated with stent implants that would prevent ischemia. 
So far, studies conducted on autopsies have been the most reliable in terms of plaques 
that cause coronary thrombosis [40]. Ex vivo measurements conducted on postmortem 
human arteries using IVUS and near infrared spectroscopy (NIRS) have correlated 
results from both modalities to show the feasibility of such a combination [41, 42]. 
This particular study proved that including a spectroscopic method improved the 
sensitivity and accuracy of diagnosis compared to using IVUS alone. Because Raman 
spectroscopy is inherently slower than OCT, the former would not be suited for 
intravascular imaging as a standalone. A combination with IVUS would be certainly 
less feasible as the associated signal generation and detection technologies are 
completely different. However, signal transduction for NIRS and IVUS also need to 
be realized by two different types of fibers. The main reason to combine NIRS with 
IVUS had been that both techniques function at a similar speed, so that the signals 
can be co-registered [41]. Apart from intravascular vibrational spectroscopy, several 
other spectroscopic approaches have been suggested and are currently under 
investigation. Fluorescence based techniques such as two-photon excitation 
fluorescence (TPEF) and FLIM are certainly fast enough to record images and have 
been utilized to characterize atherosclerotic plaques [43-46]. TPEF has been combined 
often with other multiphoton processes, such as second harmonic generation (SHG) 
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and coherent anti-Stokes Raman scattering (CARS), a much faster, but also more 
complicated variant of Raman spectroscopy [47-50]. However, for these multimodal 
techniques reliable optical fibers that are applicable for in vivo imaging need to be 
developed.  
 
One of the main differences between the two diseases investigated here had been the 
accessibility to disease locations, apart from the prevalence of the disease. Detecting 
skin cancers has an obvious simplicity compared to any other type of cancer as a 
microscopic setup is able to access the locations in an in vivo scenario. However, the 
experiments on non-melanoma skin cancers had been conducted ex vivo as it was a 
preliminary pilot study. Investigating atherosclerotic plaques in vivo, on the other 
hand, require a flexible catheter that can reach inner arterial walls for identifying 
affected regions. As part of the investigation, an OCT needle probe was built in 
collaboration with the University of Perth, Australia, that will be integrated with 
Raman spectroscopy in the future. Since both OCT and Raman spectroscopy utilize 
laser light in the NIR region, a fiber probe would be technologically feasible. Similar 
needle probes have been utilized mainly to investigate breast cancer and lung tissue 
as a puncture incision is not surgically challenging and would heal quicker which 
reduces the level of invasiveness [51, 52]. As a proof of concept the combined OCT- 
Raman investigations on arteries were also conducted under ex vivo conditions.   
 
The application of this combined setup on disease diagnostic routines, has great 
potential to reduce false positives eliminating intraoperative variations and diagnostic 
efforts [53]. The benefits would be in terms of better patient care and a positive 
economic impact by avoiding unnecessary labor costs [54]. Furthermore, the scenarios 
in operating theaters would change in a way that the surgeons will be guided through 
surgeries via live imaging with high accuracy and speed. As a final step, the presence 
and/or removal of all diseased tissue will be confirmed by a chemically specific 
spectroscopic method such as Raman spectroscopy thus avoiding patients to be called 
for a follow-up surgery. This would promote taking advantage of the high molecular 
specificity of Raman spectroscopy and highly detailed image scanning capability of 
OCT, which would help achieving an improved quality in disease diagnosis. 
 
1.1 Outline of thesis 
An outline of the chapters has been described below.  
 
• Chapter 2  presents the theory of OCT that elaborates on the working 
principle and the different types. A similar format has been used 
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for Raman spectroscopy followed by an overview of the 
combination. 
 
• Chapter 3  provides a thorough account of the implementation of the combined 
OCT- Raman device. The reasoning for using specific components 
have been explained. The preliminary tests utilized to characterize 
the device has been described as well.   
 
• Chapter 4  exhibits the results of a pilot clinical study on non-melanoma skin 
cancers. This chapter discusses the correlation of OCT and Raman 
data with histopathology.  
 
• Chapter 5  addresses the outcome of the combined OCT-Raman application 
on aortas ex vivo and in vivo to characterize atherosclerotic plaques. 
Apart from the data types dealt with earlier, X-ray imaging have 
been introduced that was used only with the in vivo experiments. 
 
• Chapter 6  investigates the feasibility of an OCT needle-probe developed for 
atherosclerotic plaque measurements. 
 
• Chapter 7 summarizes the results and provides an outlook for future methods 
to improve methodology and the analytical outcome.  
 
 
 
CHAPTER 2 Theory 13 
2 Theory 
2.1 Optical coherence tomography  
Optical coherence tomography (OCT) is an interferometric method that was 
introduced in the 90s by a group at MIT [55]. Its development for clinical applications 
took off by the successful investigations in ophthalmology as OCT was utilized to 
obtain high resolution cross-sectional images (tomography) of the retina [56, 57]. Since 
then, studies have been conducted in many fields including cardiovascular and skin 
cancer imaging, to visualize tissue pathology without laborious clinical measures [17, 
23, 58, 59]. There are a few different types of OCT systems that will be explained in 
detail in the following.  
 
 
Figure 2.1: A- cross-sectional image of a cavity observed from an excised human aorta 
collected from a spectral domain OCT (Telesto SD-OCT, Thorlabs). The tissue 
morphology beneath the surface can be seen and at the 4.5 mm mark (red vertical line) 
an A-scan was recorded shown in B. The corresponding line measurement (red arrow in 
C) has been overlaid on the camera image of the aorta.  
 
As an example, Fig. 2.1 A shows a 2D cross-sectional image (B-Scan) of an excised 
human aorta and it is composed of a collection of axial scans (Fig. 2.1 B, A-Scan). A 
corresponding camera image of the aorta (Fig. 2.1 C) shows the length where the line 
measurement had been conducted. A 3D or volumetric data set (C-Scan) can also be 
produced by stacking all 2D images of a region of interest. Thus it can be shown that 
OCT systems enable an ‘optical biopsy’ by comparing back scattered electromagnetic 
waves from the sample with that of the incident waves.  
 
The working of an OCT system is such that, first, the incident laser light is split via 
a beam splitter, whereby one part is directed to the sample and the other to a 
reflecting mirror which acts as a reference. Then, back scattered light from the sample 
and light from the reflected mirror undergo interference only when the lengths of the 
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reference and sample arms are matching within the coherence length, a property of 
the incident laser light [60]. Since the coherence length is inversley proportional to 
the axial depth resolution, broad bandwidth illumination sources (low coherence) are 
usually used in OCT imaging. Lateral resolution has no effect on the axial resolution, 
as the former depends on the spot size goverened by the objective optics. However, 
the lateral resolution at a given wavelegnth is inversely proportional to the depth of 
field [61]. Therefore the NA of the objective lens has an effect on the visualized z-axis 
range. The penetration depth is governed by the principle wavelength and the light-
sample interactions such as absoprtion and scattering [62, 63]. Since water is the main 
constituent of tissue, wavelegnths longer than ~2000 nm would result in high 
vibrational absoprtion that would reduce the achievable penetration depth [64]. 
Therefore, it is important to choose the appropriate wavelegnth for a working OCT 
device.  
 
To probe into the sample and obtain depth information, the reference arm is scanned 
a given distance (∆) as shown in Fig 2.2. This method is known as time domain 
(TD) OCT.  
 
Figure 2.2: Time domain OCT (TD-OCT) setup with a sample with underlying layers at 
the end of the sample arm.	∆ is the distance the reference arm is moved to obtain 
subsurface infromation from the sample where as ∆ is the length of the sample arm 
which remains constant. Adapted from [60] 
 
The above illustrated setup consumes time for the reference arm adjustment and 
involves moving parts resulting in reduced stability. To overcome these drawbacks, 
Fourier or spectral domain OCT (FD-OCT) has been developed where the reference 
mirror is kept at a constant position matching the length of the sample arm. The 
detector is replaced by a spectrometer followed by a high-speed line camera and the 
detected response is Fourier transformed to obtain time information, thus extracting 
depth related information.  
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Figure 2.3: Fourier or spectral domain OCT (SD-OCT) setup. The optical grating 
represents the spectrometer. Adapted from [60] 
 
Since there are no moving parts in the SD-OCT setup, all signals from the 
measurement depth are collected and Fourier transformed [65]. This may also produce 
ghost images and other unwanted artefact on the image but provides a higher 
senstivity than TD-OCT. This also means that SD-OCT has a higher signal to noise 
ratio (SNR) which can be beneficial for reducing the amount of laser power in 
biomedical applications. As SD-OCT detects all the signals from the entire depth, 
using Fourier transform the interference pattern can be reconstructed to extract 
specific responses originating from a given point in depth. In terms of depth or axial 
resolution both SD- and TD-OCT have a dependence on the spectral bandwidth of 
the source [66].  
 
Similar to SD-OCT, another type of Fourier domain OCT system known as swept 
source OCT (SS-OCT) has emerged that uses a narrow bandwidth swept source which 
avoids the use of a spectrometer but employs a single photo-detector instead. This 
type of continuous wave laser excitation provides a much larger intensity than the 
laser source used on an SD-OCT i.e. a superluminescent LED source. Therefore, SS-
OCT produces a larger tissue penetration depth [67] compared to SD-OCT. Since the 
sample signal is received at evenly spaced frequencies, applying a discrete Fourier 
transform would provide depth information [65]. With the swept source, the amount 
of noise would be reduced as opposed to the broadband source. For the results 
presented in chapters 3, 4 and 5 SD-OCT and SS-OCT have been used since they are 
the most suitable for biomedical applications in terms of sensitivity and speed.  
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2.2 Raman spectroscopy  
Raman spectroscopy generates spectra that represent molecular fingerprints of tissue 
components. As it is chemically specific and does not require the use of contrast 
agents, the possibilities of medicinal application has become an intensely studied 
topic. When laser light interacts with matter, part of the energy is absorbed and 
another part is scattered. A large fraction of the scattered light would maintain the 
original frequency (Rayleigh scattering, see Fig. 2.4) but the other smaller fraction 
would be shifted in frequency. The latter which has influenced molecular vibration, 
holds the characteristics of the molecules. This phenomenon has been named after its 
discoverer and is called the Raman effect [68].  
 
Raman scattered photons are a result of interactions which are initiated by absorption 
of an incident photon. This promotes the molecule to a higher energy state (virtual). 
Due to its unstable state, the molecule recedes to an energy state higher than its 
vibrational ground state which emits a Raman photon also known as an inelastically 
scattered photon.  The energy detected during this Stokes event is red shifted. If the 
molecule is already at a higher energy state and after emitting a photon, lands in the 
ground state, blue shifted anti-Stokes photons can be observed [69] (Fig. 2.4).  
 
Figure 2.4: Jablonski diagram showing Anti- stokes, Rayleigh scattering and Stokes 
responses. 
 
Raman scattering is limited by the change in polarizability between the ground and 
excited states as well as the molecular symmetry. The intensity of scattered photons 
relates to the polarizability and therefore Raman spectroscopy can be used as a means 
to quantify specific molecular groups [70, 71].  
 
The collection and separation of Raman scattered light is carried out by a 
spectrometer and visualized as a spectrum. Usually CCDs are used to detect Raman 
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emitted photons displayed as spectra. Excitation wavelengths in the visible light 
range produce broad fluorescence when used on tissue that masks Raman responses. 
This is because visible wavelengths contain the suitable energy difference to promote 
fluorescence. Therefore, near infrared (IR) light is used to investigate biological tissues 
as it contributes to reduced fluorescence. Wavelengths around 800 nm have shown 
optimal Raman spectral results with minimal fluorescence disturbance. However, at 
longer wavelengths, i.e. more than 850 nm, the current silicon based CCD cameras 
meet a sudden drop of detector efficiencies from 1000 – 1100 nm. Thus, an appropriate 
wavelength must be chosen for the given application.  
 
The collection of back scattered photons on a microscopic setup is carried out via an 
objective lens usually with a high-NA in order to have a wide collection angle. This 
would be then coupled to an optical fiber that guides the light to a slit on the 
spectrograph. The diverging light is collimated and directed to a grating that 
disperses the beam at varying angles which is then directed to the detector. There 
are different types of gratings and ways of fabrication but its general function is to 
separate the components of light and governs the spectrometer resolution.  
 
In order to identify the separated wavelength components, the Raman instrument 
must be calibrated using a known material, such as cyclohexane and 1,4-
Acetamidophenol to interpolate the wavelength [72]. This is a necessary step when 
replacing the grating or starting the instrument. The calibration step is important 
especially in medical applications to achieve high accuracies and to be highly 
reproducible. Once the known material has been measured, specific peaks that relate 
to certain wavelengths are associated to given pixels on the CCD. By the known 
peaks of the standard material, the wavelength can be extrapolated using a third-
order polynomial regression. Intensity calibration is also usually carried out to 
account for varying quantum efficiencies of the grating and pixels at different 
wavelengths [73]. Thus system artefacts originating from the optical components can 
be avoided. 
 
In addition to optimizing the spectrograph, the Raman backscattered photons must 
be collected with minimal loss. However, applying this setup in a clinical setting, 
requires careful consideration of the specific application. If the Raman signals must 
be collected from locations that are hard to reach, an optic fiber probe must be used 
that will not produce its own Raman spectra and resist sterilization processes in the 
hospital [68].  
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3 Material and methods 
The main goal of including two modalities with complementary strengths is to gain 
both morphological and chemical information from a single measurement which would 
save time and effort significantly. When considering the clinical workflow, OCT would 
be used first to obtain quick information on tissue morphology in order to track or 
recognize signs of disease. If any unusual sightings were to be found, the region would 
be inspected using Raman spectroscopy which identifies any molecular abnormalities. 
This chemical confirmation would be able to diagnose diseases accurately with the 
help of an algorithm or a separate database. 
 
3.1 OCT-Raman combination for clinical application 
Current clinical needs have paved the development of novel medical devices either 
for guided surgeries or early diagnosis [74]. In these applications, large tissue areas 
require real-time investigation that costs measurement time. This is an important 
factor that governs the diagnosis strategy and workflow. Compliance to standard 
clinical processes and having the advantage of a compact and mobile built are some 
key factors that the medical industry places emphasis on regarding biomedical 
devices.  
 
There have been a number of studies within the past 10 years that confirm the 
benefits of using spectroscopic and optical methods for diagnosing skin cancers. 
Majority of the groups have used fiber probes to collect data, the datasets include 
more than 100 samples and constitute of different types of non-melanoma as well as 
melanoma cancers. Some of the groups had combined Raman spectroscopy with other 
modalities such as auto fluorescence [75], diffuse optical spectroscopy and laser 
induced fluorescence spectroscopy [76]. All the statistics point towards Raman 
spectroscopy having higher sensitivity than experienced clinicians. An attempt to 
differentiate BCC subtypes using OCT had resulted in needing further information 
of the tumor constituents. However, the OCT and histopathology images possess 
similarities in terms of unorganized tissue architecture and clear inflammations but, 
to confirm the tumor subtype, only using OCT would require ultra-high imaging 
resolutions [17].  
 
Patil et al. have tested an OCT-Raman setup under in vivo clinical conditions that 
had produced results confirming the feasibility of this combination in non-melanoma 
applications. Even though Raman imaging capability was missing in the setup as well 
as sample numbers differences had been identified between cancer and non-cancer 
regions. The common focus on non-melanomas was simply due to its high occurrences 
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compared to melanomas. These types of tumors are responsible for structural damage 
in tissue even though metastasis is relatively slow. They may arise in the form of 
scars, ulcers and inflammations. BCCs generally consist of groups of unorganized 
basaloid cells at tumor centers. These islands are characteristically different from cells 
originating from the dermis and the changes in tumor content cause a clear separation 
between the tumor nucleoids and the surrounding tissue [77]. The presence of keratin 
and fibrous tissue may vary depending on the location and stage of the tumor and 
specific tumor types can be identified as nodular, superficial and infiltrating which 
have resulted in three distinctive types of BCCs. 
 
In atherosclerotic plaque imaging, OCT has been well known and have already been 
used as a guided imaging tool in surgeries such as stent implantations [78, 79]. 
Catheters are utilized to enable the OCT fiber probe to reach the relevant locations 
and the procedure takes place under X-ray examination. Once the catheter is inserted 
until past the location of interest, it is pulled back at a constant velocity while 
rotating 360o. In doing so, the entire aorta is imaged within a few minutes. However, 
to obtain clear visualizations of plaques a blood free path is required. Therefore a 
contrast agent is administered via the catheter before the pullback begins. The image 
capture therefore must be time gated with the pullback motion. The strengths of 
OCT in this application involve the ability to acquire high resolution images with the 
required sensitivity. Due to the varying sizes of plaques, the limited penetration depth 
of OCT might not provide a complete image of larger or deeply embedded plaques 
[80]. The challenging task, however, is to distinguish between calcium and lipid rich 
plaque content.  
 
Amongst the studies conducted on in vivo plaque imaging, the most common 
encounters have been ruptured, lipid rich, thin fibrous caps and calcified plaques. One 
study had quantified the amount of macrophages using OCT which can be correlated 
to the stage of the plaque [81]. The most important information extracted from thin 
fibrous caps is the thickness as it has a significant correlation to plaque vulnerability 
[79]. Even though thin fibrous caps and calcifications can be easily identified at later 
stages via OCT, early occurrences have been difficult to confirm [82, 83]. Therefore, 
combining OCT with Raman spectroscopy which can differentiate between specific 
chemical signatures would expedite the diagnostic procedure and promote better 
therapeutic interventions. Raman spectroscopy contains distinctive spectral features 
that identify calcium phosphate (960 cm-1) and cholesterol/ cholesterol ester groups 
(~900 – 1100 cm-1) [84]. There have been a few in vivo as well as ex vivo animal 
experiments investigated to conclude the presence of  high- cholesterol rich diet 
induced plaques [85]. Moreover, postmortem aorta examinations have also increased 
the confidence of Raman spectroscopy in classifying atherosclerotic plaques [86]. 
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Thus, OCT-Raman combination would enable cross-sectional images with 
corresponding chemical information which would promote early diagnosis and reduce 
death rates due to CVDs.  
 
3.2 Device implementation 
The implementation of SD-OCT and Raman spectroscopy was enabled via a probe 
cage consisting of optomechanical components from Thorlabs (OCTP-1300/M 
Adjustable Scanner, Thorlabs, Lübeck, Germany) that was mainly developed for the 
OCT system. This was modified to incorporate the Raman modality using additional 
dichroic mirrors that directed respective light paths to the sample and back to the 
detectors. Since the working wavelength range of the two modalities are quite wide 
apart, choosing the suitable objective lens was a challenge as they are mainly 
manufactured specifically for narrow wavelength ranges. However, in this chapter the 
principles behind the combination has been discussed along with the reasoning behind 
certain instrumental choices.   
 
 
Figure 3.1: A schematic of the probe cage showing the OCT (green) as well as the Raman 
(red) beam paths. Adapted from [87]. 
 
Fig. 3.1 shows the combined SD-OCT-Raman setup consisting of the probe cage 
where the control of beam paths has been achieved by dichroic mirrors M1, M2 and 
M3 at specific junctions where the beam paths cross. M1 represents two galvanometer 
mirrors (G1 and G2 Fig. 3.3) placed adjacent to one another, each directing the light 
beam downwards onto the sample. Each mirror scans in one direction, i.e. across X 
and Y directions, producing line scans over a specified FOV (max. limit= 10mm). 
One of the mirrors scan at a faster rate and both together provide a final area scan 
along with depth information. The CCD situated on top of M1, records microscopic 
CHAPTER 3 Material and methods 21 
images of the sample as the slower galvanometer mirror allows white light to pass 
while reflecting the rest. The incident beam paths of both OCT and Raman modalities 
must be coinciding spatially. This was achieved by adjusting the laser beam couplers 
of both Raman excitation beam and that of OCT at the entry point to the probe 
cage. Mirror M2 was inserted at a 450 angle with an alignment such that both Raman 
and OCT beam paths overlap (overlaid beam paths, green and red, in Fig. 3.2). It 
also allows the incident OCT beam to pass while reflecting the incident Raman light 
together with the back scattered Raman signal. Mirror M3 was aligned using a neon 
calibration lamp to achieve the highest collection efficiency (red beam path, in Fig. 
3.1) as it is responsible for reflecting Raman signals into the collection arm where 
focusing optics couple the signal to the fiber core. This collection arm consists of a 
notch filter to remove any residual signals from the 785 nm laser as well as a focusing 
lens to couple the back scattered Raman light onto the collection fiber. 
 
 
Figure 3.2. A photograph of the probe cage showing the Raman (red) and OCT beam 
paths (green) Adapted from [87]. 
 
To assist the visualization of the sample through the objective a dispersive ring of 
LEDs illuminates the sample through a wide area during measurement (Fig. 3.3) 
which assists in the sample alignment, positioning and OCT calibration.  
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Figure 3.3. Cross section of the dispersion ring that was placed around the objective lens 
to illuminate the sample. 
 
The intensity of this ring is adjustable and during Raman measurements the LEDs 
were switched off so as to avoid any interference with backscattered photons. 
 
3.3 Scanning system 
 
Figure 3.4: Galvanometer mirror scanning system. The green lines follow the path of the 
incident light rays. 
 
This galvanometer mirror set (G1 and G2) has been housed underneath the CCD 
camera that records en face microscopic images of the sample. G1 transmits UV-VIS 
light reflected from the sample to the CCD camera situated in probe cage. The rest 
of the light is reflected to G2 and in turn towards M2 and other parts of the 
instrument. The total scan speed to acquire point scans (A-scan) can be varied 
between 5.5 kHz to 146 kHz. G1 moves at a slower rate in one direction as it reflects 
the light from G2 and the latter moves quicker in the other direction to produce line 
scans that span the entire field of view. Thus, each line scan produces a 2D cross-
sectional image (B-scan) and a 3D volume scans (C-scan) have been constructed by 
a collection of B-scans as shown in Figure 3.5. 
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Figure 3.5: Definitions of A-scans, B-scans and C-scans in OCT shown using skin 
sample 
 
3.4 Dichroic mirrors and alignment procedure 
The dichroic mirrors are utilized to isolate light selectively with respect to the desired 
application. Those used in the combined OCT-Raman setup were all positioned at 
45O due to the design of the probe cage.  
  
• One of the two galvo-scanning mirrors, G1 (AHF Analysentechnik, Tübingen, 
Germany) as shown in Figure 5.4 allows visible light (~ 350 – 650 nm, blue 
arrow in Fig. 5.1) through to the CCD while reflecting 700 – 1500 nm with a 
> 93% reflectivity.  
 
 
Figure 3.6: Galvanometer mirror G1 
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• M2 (AHF Analysentechnik, Tübingen, Germany) reflects the incident Raman 
beam at a 90O angle towards the galvanometer mirror G2 as well as the Raman 
back scattered photons from the sample (750 – 1050 nm) towards the 
respective detectors maintaining an unchanged OCT optical path (see Figure 
5.1).  
 
 
Figure 3.6: Transmission response of the dichroic mirror M2 at 450 
 
As shown in Fig. 5.5, at a 45O angle this mirror exhibits a small kink in its 
transmission response which results in a fair deformation of Raman spectra at 
around ~ 2700 cm-1. This is further seen on Raman spectra shown in the 
Results section.  
 
• The role of M3 (AHF Analysentechnik, Tübingen, Germany) is such that the 
back reflected Raman signals (750 – 1050 nm) are directed towards the 
detector while transmitting the incident Raman laser light. The profile of this 
mirror is the opposed to that of M2 with a high reflectivity in the range of 750 
– 1050 nm.   
 
The alignment procedure of the system involves controlling many parameters 
simultaneously. First, the OCT beam path was adjusted using the laser couplers such 
that the input OCT laser beam was collimated onto the optical axis of the beam 
splitter cube and the reference arm (green beam path in Fig. 3.2). Then mirrors M2 
and M3 were inserted and aligned at a 450 angle. Calibration of mirrors G1 and G2 
was conducted by an inbuilt calibration software on ThorImageOCT and this step 
was carried out for each objective lens before any measurement. The reference arm 
length was adjusted according to the objective lens used and the reference arm power 
needed adjustment relative to the iris situated on the arm. This step was necessary 
to compensate for the different working distances in the objective lenses and the 
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centering of the reference path length with the aperture. By adjusting the tilt of the 
beam splitter, the maximum intensity response was registered while the iris was fully 
open. Then, the opening diameter was gradually reduced while adjusting the beam 
splitter tilt-angle until the intensity variation shows the highest sensitivity to the 
aperture movement. After this step, the reference arm mirror was aligned until the 
surface of the sample was at ~ 3 mm on the axial scale as this position produced the 
least number of artifacts such as sharp intensity peaks in cross-sectional images due 
to the reflections from the sample surface. Moreover, this adjustment was necessary 
for the alignment of both axial foci of Raman and the OCT system that obviously 
needed to be overlapping. For the Raman counterpart, a pure powder sample of 1,4- 
Acetamidophenol was measured to achieve the highest signal intensity and the OCT 
reference arm was then adjusted to compensate for the axial distance mismatch.  
 
The software that controlled the functioning of both modalities is based on LabVIEW. 
The data acquisition of OCT, Raman as well as the laser power were controlled by 
combining the already available OCT LabVIEW Software Development Kit with the 
LabVIEW components of the Raman spectrometer. OCT B- scans are stored in ‘.fits’ 
format and by stacking the B- scans, a C- scan was produced using the 3D Viewer 
plugin on ImageJ. The Raman data are stored in ‘.txt’ file format along with the 
coordinates so that the data localization would be feasible during data analysis.  
 
In practice, the alignment was a challenge and the OCT and Raman beams were not 
overlapping spatially at the sample plane after the Raman system was optimized for 
the highest data quality achievable. This produced a discrepancy between both 
Raman and OCT laser spots which was observed on microscopic images. This issue 
was solved by measuring the difference in distance of misalignment (2.22 mm) and 
adding this parameter to the LabVIEW software so that the coordinates would be 
adjusted during the data saving process. Allowing this offset to persist would have 
caused a mismatch in our coordinate system and may even mislead the final 
statements.  
 
3.5 The Raman spectrometer and SD-OCT system 
The table below lists the specification of both the Raman and SD-OCT system with 
respect to different components such as laser source, detector and spectrometer 
specifications. 
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Table 3.1: SD-OCT and Raman spectrometer in terms of laser source, detector and 
spectrometer specifications. NOTE: For some measurements (porcine and system 
characterization), a Kaiser Raman spectrometer was used and these specifications will be 
mentioned on the relevant results sections.  
Component Raman system SD-OCT 
Laser source 785 nm narrow linewidth laser- 
MatchBoxTM from Integrated 
Optics, UAB. As the name 
suggests, the laser was as large 
as a match box. 
Broadband super luminescent 
diode (SLD) with the central 
wavelength at 1325 with a 
bandwidth of > 100 nm.  
Detector Andor DU420A BEX2-DD 
configuration 
Goodrich SU-LDH, digital high 
speed InGaAs line scan camera   
Spectrometer Andor Shamrock 303i in Czerny 
turner configuration with a 
grating 300 l/mm with a 3.40 
nominal blaze angle. 
Uses a linear-k spectrometer 
with a diffraction grating, and a 
prism for spectral dispersion.   
 
The Raman spectrograph grating was aligned using the built-in motorized, indexed 
triple grating turret. The Andor CCD camera coupled with this spectrograph 
consisted of 1024 × 256 pixels and is a back illuminated, deep depletion CCD camera 
with fringe suppression and AR coating. Before any measurements, the detector was 
cooled to -60 0C and maintained at this temperature throughout.  
The SD-OCT device used was also based on a spectrometer setup. Since it had 
acquired cross-sectional information all at once, Fourier transformation had been 
applied to produce the final 2D image from the interference patterns. Thus, the 
acquired signals needed to go through a post-processing step that may have costed a 
few seconds after measurement. During data processing, different contributions from 
the system was manipulated so as to extract the sample information and the signal 
quality in OCT was mainly governed by the scan speed and the detector readout 
rate. The acquisition rate of this OCT device ranged from 11 µs - 181 µs per A-scan. 
The OCT signal received via the single mode (SM) fiber contained a large 
contribution from the reference arm response which had been removed as a 
preliminary step in signal processing. Normally, the frequency of the reference signal 
was lower compared to that of the interference fringes of the sample thus isolating 
the reference signal was feasible. Another contribution received by the detector 
consisted of the DC component that represents those reflections from the reference 
mirror and the sample that do not contribute to the interference term. In addition, 
the autocorrelation term that originates from resulting interference between the 
different layers within the sample was another artefact present in captured OCT 
images. These two components had been filtered allowing only the cross-correlation 
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term to be used for image processing which consisted of valuable sample and reference 
information. Reflections (with respect to SD-OCT) from the sample across the z-axis 
are given by the square of the Fourier component in k- space that magnifies even 
small amounts of detected photons. The detector itself had its own offset (part of the 
background) that shifted the spectrum axially up or down along the axis that had 
been subtracted as well. Even though axial resolution is governed by the spectral 
bandwidth, during the Fourier transform step the resulting side lobes can cause 
spectral leakage. With biological samples, the acquired spectrum was never smooth 
due to non-uniformities in scattering by the different cellular organelles. Large back 
scattered signals can produce large side lobes that reduce the axial resolution. Since 
it was difficult to estimate the input frequencies accurately a window-function had 
been chosen as a precaution which had been then multiplied with the spectral 
response. In our SD-OCT system, a Hann window was applied (also known as 
apodization). These processes were part of the deconvolution method where the 
relevant interference patterns were extracted from the interferogram.  
 
3.6 Objective lens 
In terms of the working wavelength range of the combined system, both OCT and 
Raman spectroscopy were far apart as they functioned at 1325 and 785 nm 
respectively. While deep tissue OCT imaging requires objective lenses with a rather 
low numerical aperture (long working distance), Raman spectroscopy requires 
relatively larger numerical apertures to achieve higher collection efficiencies. The 
perfect objective lens for combining OCT and Raman measurements would be always 
a compromise for both modalities. However, an anti-reflection (AR) coating and 
transmission wavelengths from 700 – 1500 nm are advantageous properties to have. 
Initially three different commercially available microscope objectives specially 
designed for OCT imaging systems were tested and detailed information can be found 
in Table 3.2.  
 
Table 3.2: Details of the telecentric objectives LSM02,-03 and -04 line from Thorlabs.  
LSM02 LSM03 LSM04 
f= 18 mm, NA= 0.11, 
magnification of 10x, 
working distance 7.5 mm 
f= 36.0 mm, NA= 0.056, 
magnification of 5x, 
working distance 25.1 mm 
f= 54.0 mm, NA= 0.037, 
magnification of 3x, 
working distance 
42.0 mm. 
 
Two more objective lenses were also tested: Mitutoyo M Plan Apo NIR Infinity 
Corrected Objective (5x, NA=0.14, Edmund Optics, US
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doublet lens with AR coating (diameter = 25mm, f= 35mm-NIRII, NA= 0.36 
Edmund optics, US).  
 
The testing criteria included optimum Raman intensities, low fluorescence 
backgrounds and clear OCT images. The three LSM objectives are telecentric, which 
had ensured minimal image distortions (for e.g. due to the varying thicknesses 
throughout the different areas of the objective) and a constant image resolution due 
to the spot size behaving evenly on flat image planes during scanning. For this same 
reason, the probe head was calibrated for each objective prior to the measurements. 
In addition, the OCT reference arm length was adjusted each time the objective lens 
was changed. The final objective lens testing process had included the application of 
the mentioned objectives on a porcine sample that had produced results proving the 
superiority of the achromatic doublet lens from Edmund Optics for this particular 
system. 
 
3.7 Integration into the medical cart 
Before introducing the system into the clinics, all the instrumental components were 
integrated onto a medical cart (WISAP® medical technology, Brunnthal, Germany) 
for ease of mobility thus further complying with medical standards (see Fig. 3.9). 
This provided the freedom to move the system without affecting any aligned optical 
components. In clinical settings, this feature had been very useful as it was 
transported many times via the elevator to different departments without any 
internal misalignments. As the system was built for clinical use, stability and mobility 
were two essential features that it needed to fulfill. Therefore, the instruments were 
kept on slip-free rubber sheets/ double sided tape and the CPU was well bound to 
the cart by a harness. After moving the system through elevators and corridors, the 
alignment and instrument positions had not fluctuated while transportation.  
 
Since Raman spectroscopy is light sensitive, the probe head and the spectrometer 
were light proofed by covering the shelves that they were housed in, with light 
blocking material. A coverage of two layers of the light proofing material surrounding 
the probe head as well as the Raman spectrometer were required for the complete 
omission of ambient light. The material was held via Velcro adhesive tape over the 
shelves and access to the probe cage was enabled by magnetic stripes glued onto the 
openings). This allowed for quick and flexible light proofing with easy access to the 
probe cage.  
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Figure 3.9: Integrated OCT- Raman system on the medical cart. A zoomed photograph 
of the probe head chamber is shown as an inset.  
 
A probable issue with combining two modalities would be the combination of data 
acquired in the z- axis (depth). Khan et al. [88] had measured a phantom as well as 
biological tissue with layered structures. Since their system was a confocal Raman 
system and the FOV was 10 folds smaller than that of our combined OCT-Raman 
setup, depth localization was possible. However, there would be many challenges if 
their system were to be applied in clinical conditions as the OCT images collected 
would need to be larger along with impeccable image quality for the clinicians to 
diagnose with the 2D scans of tumor regions. 
 
Besides the data correlation, the most challenging task in terms of the equipment had 
been the choice of a suitable objective lens. Since the device combines wavelengths 
ranging from 785 to 1325 nm (a difference of 540 nm), opting for a commercially 
available objective lens would have required the exchange of the light sources so that 
the difference in wavelengths would become smaller. However, this would have 
depleted the device performance drastically. In terms of the refractive index (NA) 
Raman spectroscopy requires a higher NA than OCT as it increases the probability 
of back scattered photon detection. The desired NA for this would be a value close 
to ~0.9. On the other hand to achieve good lateral resolution with OCT imaging, a 
lower NA objective would be required [13]. The used combination of wavelengths 
fulfill high axial resolution (OCT) and results in low fluorescence background (Raman 
spectroscopy). Since the wavelengths of the systems were ideal for the application, 
there should be a solution in terms of the objective lens, which was why a compromise 
had been made. In the method presented by Mahadeven-Jansen’s group, single 
spectra had been collected from the axis of the objective, which had not produced 
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any artefacts at the edge of the FOV. Since our strategy included a scanning method 
for both OCT and Raman spectroscopy, the effects of the objective lens was observed.  
 
The reasoning behind choosing these wavelengths relates directly to light-tissue 
interaction principles. Using wavelengths in the UV region to measure Raman bands 
would result in doubled fluorescence especially when investigation biomaterials. A 
large fluorescence background can mask the Raman response even though 
theoretically, it would provide a better SNR and stronger Raman scattering. Those 
wavelengths larger than 785 nm, such as 1064 nm which has been used very commonly 
with tissue sections, would reduce the fluorescence response significantly. However, 
this effect is coupled with reduced Raman scattering efficiency, which is inversely 
proportional to the wavelength i.e. λ. Since our application on non-melanoma skin 
cancers had large time constraints, utilizing a 1064 nm laser source was not possible. 
A workaround for using the advantages of 1064 nm would be to implement a real 
time diagnosis based on Raman and OCT images that would cut down the waiting 
period for patients. The more common silicon CCD detectors would need to be 
replaced with an InGaAs one as the former becomes insensitive above ~1000 nm.  
 
In terms of the OCT laser wavelength, using wavelengths lower than ~1000 nm would 
have reduced the quality of data and would result in sacrificing the penetration depth. 
This is because at longer wavelengths, especially at the ‘tissue optical window’ light 
is able to penetrate the tissue surface. The limit of transparency would be reached by 
water where vibrational absorption dominates at 2500 nm. Furthermore, longer 
wavelengths have less multiple scattering events as they enter tissue which promotes 
more scattered photons. In contrast, only a tissue transparency less than a 100 µm 
would be reached with lower wavelengths as the photons would lose their energy quite 
quickly. For example, Evans et al had applied a combined OCT-Raman system to 
measure bovine retinas [36] since the primary application of OCT had been to 
investigate retinal health. Their setup consisted of a Raman excitation wavelength of 
633 nm and an OCT counterpart at 855 nm. The different layers that built the retina 
was relatively thin that the penetration depth of the OCT excitation laser was 
sufficient to visualize the structures. Even though their results achieved very good 
OCT 3D images, the Raman spectra were dominated with noise and therefore had 
poor signal to noise ratio (SNR).  
 
In our application, improvements to the software would be required to achieve a 
smoother workflow. Firstly, multiple prompts must be implemented so that the user 
would not miss any important saving steps. The detector configurations must be 
embedded into the system that will not allow the user to access or change them. For 
further clinical applications with this device, a more robust software application 
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should be developed with better computational power to be able to view 3D images 
collected by OCT. The images that had been collected were post processed by ImageJ.   
 
The next section presents the experimental results carried out to obtain system 
characteristic followed by the preliminary results on commercially available pork 
samples.  
 
3.8 System characterization 
3.8.1 Measuring system resolution  
For the OCT counterpart a roll of scotch tape was used to measure the axial 
resolution. In this simple experiment the adhesive layer between consecutive tape 
layers were measured and it was found that the value stayed constant at ~ 10 µm 
with the different objective lenses used because the axial resolution only depends on 
the source bandwidth and the OCT- spectrometer resolution. 
 
 
Figure 3.10: Axial resolution images measured using scotch tape to compare the three 
objectives in question. Insets at the bottom right corner show the distance of the glue 
between the tape layers which was measured to be ~ 10 µm (white arrows). Adapted 
from [87]  
 
The lateral resolution was also characterized using a 50 µm thick tape that was placed 
on a glass slide assuming that the tape has a straight edge. Resulting mismatch 
between the distance of the proximal and distal surfaces of the tape was found to be 
approx. 13 µm (Fig. 3.11 A). 
 
 
Figure 3.11: OCT images of scotch tape (left) and a glass cover slip placed on a glass 
slide (right). The mismatch of the proximal and distal surfaces was found to be 13 µm in 
both cases. Adapted from [87]  
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To further confirm this finding, a cover slip was placed on a glass slide and line scans 
were measured across the edges using OCT. This resulted in the same mismatch as 
earlier (Fig. 3.11 B).  
 
In order to characterize the Raman imaging counterpart, a raster scan was performed 
on a Teflon layer with a scanning step size of 20 µm, mapping a region of 20 × 500 
px. The Teflon layer was taped over a quartz slide and measured across the edge. At 
a representative Raman peak at 338 cm-1, the intensity variations were recorded. To 
quantify the changes, the peak area was plotted with respect to the measured 
distance. The lateral resolution was thus defined as the distance between the intensity 
change between 10% and 90% of the integrated peak (area) as shown in Fig. 3.12 A. 
The achievable resolution was 104 ± 6 µm which was in fact in good agreement with 
the core diameter of the Raman excitation fiber (Thorlabs, M43L02, NA=0.22).  
 
Figure 3.12: Lateral resolution (A) measured across a teflon tape (peak at 338 cm-1) and 
axial resolution (B) in air using scotch tape (peak at 493 cm-1). Adapted from [87] 
 
As for the depth of focus of the Raman excitation laser light a transparent scotch 
tape was used. The tape was wrapped around a metal slide that contained a wide 
opening. Therefore by changing the Raman focus across the z-axis, within a height of 
27 mm only the material itself was measured. After recording Raman spectra at each 
0.225 mm, an intensity variation graph was produced by integrating the measured 
peak at 493 cm-1. The depth of focus was then calculated as the FWHM of this 
intensity profile (Fig. 3.12 B) that was calculated to be 5.8 mm. This observation was 
the result of measuring in air as it is vital to consider the refractive index of the 
sample when calculating depth of focus. In biological samples the refractive index is 
generally 1.4 and which results in a depth of focus of about 1 mm for the 785 nm 
wavelength used. In conclusion, our investigation resulted in a Raman spot size with 
a lateral resolution of ~ 100 µm and 700- 1000 µm axially in tissue [87].  
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3.8.2 The choice of objective lens 
There were many criteria that needed considering when testing different objective 
lenses for our application. Our systematic approach was to pick the most suitable 
objective lens from the LSM series from Thorlabs and then compare that with the 
other two objective lenses in question. Despite having the highest numerical aperture 
(see Table 3.2) from the entire LSM objective lens series (Thorlabs), LSM02 only 
transmitted 10% of the Raman signals. LSM03 on the other hand produced its own 
Raman signal that masked any sample signals leaving LSM04 as the most appropriate 
option amongst the series. As the next step, the SNR was compared between 
Mitutoyo, LSM04 and Edmund Optics achromatic doublet lens using a reference 
sample i.e. a pure powder sample of 1,4- Acetoamidophenol. As shown in Fig. 3.13, 
the achromatic doublet lens demonstrated a far superior back scattered Raman signal 
as well as a lower fluorescent background compared to Mitutoyo and the LSM04 
objective lens. Out of the LSM series, the latter had the best signal output. For this 
measurement, the RAMAN RXN1 (Kaiser Optical Systems, USA) spectrometer was 
used with a 785 nm multimode laser source, Invictus TM (785-nm NIR laser, Kaiser 
Optical Systems, Inc.). This setup included a HoloPlex, holographic transmission 
volume grating and an ANDOR iDus 420 BB-DR CCD camera. All spectra were 
measured at the same laser power and integration time.  
 
Figure 3.13: 1,4- Acetoamidophenol measured using Mitutoyo objective (left, black), 
Edmund optics lens (left, red) and LSM04 (right). 
 
Another criterion that needed to be considered was the alignment of the main optical 
axis of the objective lens with the galvanometer mirrors so that the OCT calibration 
would be accurate. The diameter of the objective lens must be at least 6 × 6 mm to 
align with the galvo mirrors. Otherwise the system calibration would not proceed to 
completion due to blocked beam paths.  Mitutoyo had a smaller diameter that cut 
out nearly 50% of the images proving it unsuitable.  
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3.8.3 Application on biological tissue 
A complete overview of all the objective lens (LSM03, LSM04 and achromatic 
doublet) performance was investigated by carrying out measurements on biological 
samples. Commercially available pork loin samples (~1 cm thick) consisting of bone, 
fat and muscle tissue were chosen. A ~50 × 50 mm piece was carefully extracted using 
a scalpel and was placed on a petri dish for measurement. For each objective lens, a 
fresh sample was used as it would lose its moisture throughout the measuring process. 
 
First, with the achromatic doublet lens, a microscopic image was recorded with a 10 
x 10 mm FOV utilizing the CCD situated on the probe head followed by a C-scan 
using the ThorImageOCT software (Fig. 3.14 I and J). The surface C-scan shows 
more detail that cannot be shown by a magnified VIS image even though the eye can 
differentiate bone, fat and muscle by the color. Since the OCT image has not been 
color coded to represent the corresponding regions it would be impossible to 
distinguish between muscles, fat and bone by only inspecting OCT images.  
 
Figure 3.14: Microscopic image (left) and the corresponding surface C-scan of a pork loin 
sample. Adapted from [87] 
 
Then, without moving the sample position, a Raman map (100 × 100 pixel size) was 
measured with an integration time of 1 second and ~40 mW laser power at the sample 
plane. Fig. 3.15 K shows the Raman map and Fig. 3.15 L shows the mean spectrum 
of each cluster after data analysis. Pre-processing steps of the Raman map include 
wavenumber calibration using 1,4- acetoamidophenol, a baseline subtraction via the 
SNIP algorithm [89] and followed by vector normalization. For the analysis step a k-
means cluster analysis with k = 5 was applied to identify spectral variations within 
the sample.  
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Figure 3.15: Measured Raman map (K) and results from the k-means cluster analysis (L) 
showing spectra representing each detected region. 
 
With the achromatic doublet lens, only a transmission loss of 10% of the laser power 
was observed as seen by the signals in Stokes Raman region between 785 – 1050nm. 
This is also reflected upon the cluster images (Fig. 3.15 K) where all tissue 
components have been separated spectroscopically including the tissue transition 
regions. Cluster 1 (dark blue) represents bone whereas bulk fat has been identified by 
cluster 3 (green). The representation of bone by the first cluster was further confirmed 
by the lowest signal recorded at the longer CH stretching region (~2800 – 3000 cm-1). 
Cyan (cluster 2) identifies the muscle regions on the sample but it is clear that the 
margins between each tissue type contain another type of tissue. It has been 
concluded that they consist of a mixture of both tissues which cannot be seen on 
either microscopic or surface OCT images. Since our system is not confocal the 
spectral features are mixed and hard to pin-point by eye. The 3D surface images 
obviously contain information from the entire scanned area, which can be 
manipulated to obtain further depth information to investigate the structures beneath 
the surface. Since the shape of the Raman spot is oval in shape i.e. elongated in the 
axial direction, the depth correlation of the data has not been possible which would 
be very useful as the accuracy of the results would increase. Confocal setups were not 
considered since the FOV would be limited and the time taken for measurement 
would be large for our application.  
 
The measurement procedure was repeated with the LSM03 and LSM04 objective 
lenses. The corresponding microscopic, surface 3D OCT, Raman map and the result 
of the k-means cluster analysis images are shown in Fig. 3.16.  
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Figure 3.16: Comparing LSM03 and LSM04 by measuring pork loin samples. The first 
row (A, B, C and D)consists of the microscopic images of the sample area, the OCT C-
scans seen from surface and the k-means cluster images derived from the Raman raster 
scan of the same area, respectively. The second row shows the same but with the lens 
LSM04.  
 
The Raman spectra collected via LSM03 resulted in large bands at 1160, 1250 and 
1360 cm-1 most probably due to the optical glue within the lens material itself. 
Therefore, the clustering resulted in poor differentiation of spectra with cluster 1 and 
2 that merged bone and muscle, 3 and 4 denoting bulk fat while cluster 5 the fat-
muscle margin. In terms of the OCT imaging, as Fig. 3.16 B, shows the image seemed 
to be thinned down. This is an after effect of adjusting the contrast after image 
acquisition, which had been applied to all the 3D OCT images. In contrast, LSM04 
displayed only a smaller Raman contribution thus resulting in more sample specific 
signals. The SNR at 1440 cm-1 was 64.3 with just 25% of the excitation laser power 
that might have corresponded to a low numerical aperture.  
 
Since the OCT calibration software has been specifically developed for the LSM 
objectives, the OCT calibration process did not perform too accurately with the 
achromatic doublet lens. This is because the OCT calibration process seemed to have 
worked by detecting the reflected light from the metal calibration sample that was 
provided upon purchasing the OCT device. Therefore, the reflected light captured by 
the achromatic lens had not been optimal for an accurate calibration, even though 
the calibration procedure was completed. Everything considered, it has the best 
compromise between the quality of Raman spectra and OCT images. The SNR of 
248.5 achieved with the doublet lens is 4 times better than the SNR obtained with 
LSM04 at 64.3. 
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3.8.4 Preliminary measurements on pork skin   
A pork skin sample with a pigmentation was chosen to investigate the morphological 
changes via the combined OCT-Raman system. The reason behind choosing a pork 
skin sample is due to the proclaimed similarity to human skin [90]. Similar to the 
measurement procedure with the pork loin sample previously, a microscopic image of 
the region of interest was captured after which an OCT C-scan was performed. As 
Fig. 3.17 B suggests the area above the red dotted line consisted of the pigmentation 
whereas the tissue below was of normal tissue.  
 
 
Figure 3.17: A photograph of the red pigmented region on a pork skin sample is shown 
in A and a microscopic image (B) shows the clear separation between the pigmented 
region and the normal region indicated by a red dotted line. The black dotted line on B 
was the OCT B-scan was conducted. Adapted from [87]   
 
There was a slight intensity variation observed on the microscopic image and this 
must have been due to the cut-off wavelength at 650 nm of the dichroic galvo mirror. 
This uneven illumination could also be a circumstance of the poor OCT calibration 
due to the achromatic doublet. Nevertheless, the OCT images represent the usual 
skin layers with a disarrangement of tissue structure where the red pigment was 
located. The black dotted line on the UV-Vis image (Fig. 3.17 B) corresponds to the 
cross section of the measured OCT line scan (Fig. 3.18). 
  
Figure 3.18: shown in C where the red pigment is observed as a hemorrhage within the 
skin layers and it is a size of 30 – 35 µm. Adapted from [87]   
 
The normal structure of pork skin was not observed probably due to the 
cleaning/sterilization processes that are being carried out commercially. However, an 
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inclusion between the tissue layers has been observed as indicated by the white arrows 
on the OCT image (Fig. 3.18). This abnormal feature had a thickness of about 30- 
35µm which was measured with OCT.  
 
In order to extract spectral information 10 spectra from each region i.e. pigmented 
and normal were collected with Raman spectroscopy using an integration time of 1 
second. Since the depth of focus of our Raman laser spot is about 1 mm, the 
measurements would consist of molecular information from these depths. Fig. 3.19 
shows the mean Raman spectra of the pigmented and normal spectra which are 
overlaid after the data had been base line corrected and normalized.  
 
 
 
Figure 3.19: Mean Raman spectra from the pigmented region (red) and the unpigmented 
(‘normal’) region (black). Representative Raman peaks are labelled.  
 
The main differences observed here have been mostly in Raman intensity of specific 
peaks. These peaks are C-H related and observed at 1298, 1443 and 2850- 3000 cm-1. 
As expected Raman spectral band of skin were present at 1660, 1270, 1030 and 1000 
cm-1. Even though, it was suspected that the red stain was a subcutaneous 
hemorrhage no heme-groups were visible in the Raman spectra. This could be due to 
the relatively small size of the hemorrhage compared to the area of back scattered 
photons collected from healthy tissue. In addition, the spectra collected were noisy 
and identifying heme related peaks would be challenging by eye. Therefore, further 
studies would need to be conducted under same conditions to have a larger sample 
set.  
 
This chapter has presented detailed information on the system development, 
characterization and the results from the different objective lenses carried out on 4 
pork loin samples. Thus, a thorough understanding of the limitations in terms of 
performance and the spectral response have been identified. The achromatic doublet 
normal 
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lens, that had the least transmission loss and had not produced an inherent Raman 
spectral response, was clearly the best option for our application. With this objective 
lens, a clear differentiation of tissue types was achieved with the help of k-means 
cluster analysis. Clear microscopic images of the samples and detailed B- and C- scans 
were obtained that were correlated to Raman spectral features.  
 
The main aim of investigating the system parameters was to confirm its suitability 
for the application on human skin samples and therefore, both axial and lateral 
resolution of both the modalities were measured. OCT was able to resolve ~10 µm 
axially and 13 µm laterally. Considering the tissue features that needed to be resolved, 
these values were suitable for investigating skin tissue. Concluding the optimal 
conditions for Raman measurements were not straightforward. Since the incident 
laser beam experiences scattering and absorption when interacting with tissue layers, 
the measured axial resolution (~5.8 mm) was not representative. In tissue this would 
be reduced to 700- 1000 µm [91]. Our system not being confocal allowed the detection 
of spectral response from a larger area within the tissue, but with poor axial accuracy. 
Scanning tissue axially with a confocal Raman system would cost more time but 
would provide highly localized depth information, which may be useful in in vivo 
diagnosis as well as during tissue biopsy. This limitation was observed first hand 
during the pork skin pigment investigation. It was concluded that the amount of 
hemorrhaging was too small (~35 µm) compared to the amount of normal skin that 
was present in the measured Raman cross section. However, differences were observed 
with OCT scans as a darker inclusion between tissue and distinct intensity variations 
in Raman spectra.  
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4 Results and discussion 
Having demonstrated that the combined OCT-Raman system provides convincing 
results in tissue visualization and spectroscopic differentiation, a pilot clinical study 
has been initiated in collaboration with the SRH Wald-Klinikum hospital in Gera, 
Germany. Furthermore, ex vivo atherosclerotic plaques, both human and animal, were 
investigated in order to observe the system performance and capabilities. In vivo 
animal experiments were then conducted using separate systems, as a proof of 
principle. Here, the Raman spectroscope used was previously described, i.e. Raman 
RXN1 (Kaiser Optical Systems, USA), and the OCT system was a commercially 
available device (St. Jude Medical, US). This chapter focuses on the measurement 
protocol, system performance and the quality of data in all three applications.  
 
4.1 A pilot clinical study 
The main goal of applying the OCT-Raman system in a skin cancer study was to test 
the feasibility in differentiating ex vivo non-melanoma skin cancers as well as the 
overall applicability in a surgical environment. As expected, many types of cancers 
were included in the patient pool as it was impossible to identify the diagnosis without 
an H&E stain. The patients were informed of the experiments beforehand and an 
agreement was signed which had gone through an ethical vote. The main focus was 
on BCC tumors as their prevalence is high compared to other non-melanomas [92]. 
Moreover, the Raman spectral quality of BCC tumors compared to other met tumor 
types enabled a better correlation between microscopic, OCT and Raman images. 
According to the histopathologic outcome, the BCC samples were handpicked and 
used in the data analysis.  
 
Sample preparation: Skin samples were extracted by a surgeon using a scalpel. Each 
time their size and shape varied such that the diameter of the samples ranged between 
3 – 15 mm depending on the location of extraction. After careful extraction the 
samples were placed on a gauze and was handed over for OCT and Raman 
measurements.  
 
The OCT-Raman device was initialized well before the beginning of the biopsy as the 
detector required cooling which took a few minutes. The instrument was placed in 
the adjacent room, next to the operating theater. The samples did not require any 
cooling. Initially a few drops of saline were added onto the surface of the sample to 
avoid any drying during measurement. The saline was only added onto the gauze to 
supply some moisture that would avoid any drying effects during measurement. The 
total time required for both OCT and Raman spectroscopy measurements was only 
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12 minutes per sample and within this period no significant drying had occurred that 
could mislead the diagnosis of the pathologist. After the measurement, the samples 
were immersed in a vile of formalin and transported to the pathologist for H&E 
sectioning. 
 
A total of 18 patients were involved in this study with 28 being the total number of 
samples. After the first 8 patients there was a change in the system settings and 
alignment. (Note that the 8th patient was not included in the study as the OCT image 
acquisition was not recorded successfully). Therefore, the first 7 patients (8 samples) 
were analyzed separately and those samples were diagnosed to have BCC, SCC and 
pre-cancer types as shown on Table 4.1 (even though the main focus was on BCC).  
 
Table 4.1: Summary of the first 7 patients and related information. The sample 
highlighted in green has been presented in detail later (Fig. 4.1) 
Patient 
no. 
Region 
of 
extractio
n 
No. of 
samples 
per 
patient 
Diagnosis- 
pathologist 
Microscopic 
image 
01 Face 1 Superficial BCC 
 
02 Face 1 Partially eroded 
partially 
keratinized BCC 
 
03 Back 2 Hyperkeratosis (sun 
exposure) 
 
Nodular BCC 
 
 
04 Face 1 Partial superficial 
minimal BCC 
 
05 Face 1 Multifocal 
superficial BCC 
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06 Face 1 Partially eroded 
superficial BCC 
 
07 Back 1 Solid BCC 
 
 
The system change involving the use of a fiber with a smaller diameter made the 
system alignment very sensitive at a cost of the signal-to-noise ratio and did not 
improve the subsequent data analysis. At least half of the samples had a too high 
fluorescence background which hindered a detailed analysis.   
 
Data analysis: The Raman spectra shown in Figure 4.1 D, are that of the fingerprint 
region since the high wavenumber regions did not contain any useful spectral features. 
The lower wavenumber region had a system background response that had distorted 
any usable spectral information. This background response consisted of fluorescence 
and an etaloning filter function that had been reduced with the background correction 
algorithm [89] and Savitzky-Golay smoothing, respectively. With a simple clustering 
method as k-means, a distinguishable separation between diseased and normal tissue 
was achieved. 
 
Results and discussion: The collected results were compared with one another for 
correlation. OCT images (B-scans and C-scans), Raman spectra and images of H&E 
stains of the sample from patient #04 (highlighted in green on Table 4.1) are shown 
in Figure 4.1. 
 
CHAPTER 4 Results and discussion- A pilot clinical study 43 
Figure 4.1: Comparison of OCT and Raman results obtained from a BCC skin biopsy. 
The microscopic image (A) of the sample has been overlaid by Raman spectral 
measurements (1 sec. integration time per data point). This can be seen on the C-scan 
in image B as well. The approximate region where the H&E cut has been made has been 
shown by the dotted line on the 3D volume. From the OCT image slices (B-scans) across 
the sample, the features observed on the H&E slice were matched as shown in C. The 
Raman spectra collected from the vertical and horizontal axes were analyzed using k- 
means cluster analysis and the corresponding spectra have been shown in D.  
 
The sample shown in Figure 4.1 A was extracted from a region on the face and the 
microscopic image, which provides an en face view of the sample, revealed the 
topology of the skin surface. The red square, overlaid outlining the Raman 
measurement spots on both x and y axes, shows the FOV of the OCT measurement. 
A closer look at the diagonal of the image would display the vascularization where 
the bulging regions were situated. This may be a result of the local inflammation 
caused by an accumulation of lymphocytes. An abnormal redness in the mid region 
of the FOV was diagnosed by the pathologist as partial superficial minimal BCC 
(Table 4.1). This specific sample was one of the exceptions that showed the presence 
of tumor on the microscopic image. In many instances, the tumor had been submerged 
or not confined to a certain region due to the physiology of BCCs.  
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The OCT C-scan of the sample (see Fig. 4.1 B) exposes the topographic details and 
it has been tilted for better visualization. This image has been overlaid by the Raman 
data points to show the location of the Raman line scan. Since the H&E slices had 
not coincided with the exact OCT cross sections only an approximate comparison 
was achieved between the H&E image and the OCT B-scans. The recorded resolution 
of 13 µm was sufficient to visualize the relevant topographic features. The 800 2D 
OCT scans were accessed separately and with careful inspection, three OCT 2D scans 
were found to correlate with the histology observed on the H&E stain (Fig. 4.1 C). 
Concerning the Raman spectra, only the tumor and tumor borders were identified on 
the H&E stain as shown with the corresponding colored line (red and green, Fig. 4.1 
C). However, the three B-scans have depicted the information matching those circled 
in Fig. 4.1 C I, II and III. Tumor granules can be clearly seen in C I and the flaky 
surface texture of the lesion in C II. Shadowing from the epithelium had resulted in 
obscured images of the dense collection of the cells beneath the surface. However, this 
feature was found on another B-scan in the data set. The relatively large tumor 
nucleoids (Fig. 4.1 C III) were found at a depth of 1 mm which was confirmed by the 
B-scans. The entire measurement lasted ~12 minutes and included collecting (and 
saving) OCT images as well as Raman spectra.  
 
The Raman measurements were analyzed using k-means clustering which resulted in 
three different spectral clusters shown in Figure 4.1 D. The spectrum in green has 
been assigned to the tumor region whereas red cluster to the tumor border which 
contains a mix of normal as well as tumor tissue. From the microscopic image (Fig. 
4.1 A) it was not possible to conclude how deep the tumor had invaded. With the 
penetration depth achieved by the Raman spectrometer system, the collected spectra 
contain chemical information from a depth of nearly 1 mm. Significant differences 
among spectra had been mostly intensity differences in the following regions: ~800- 
900 cm-1, ~1000- 1100 cm-1, ~1350- 1450 cm-1, at 1449 cm-1 and ~1500- 1700 cm-1. 
Spectra below 900 cm-1 had contained background due to system components. Thus, 
this region was subtracted from the analysis. The sample from patient #2 which had 
been extracted from the face and diagnosed as partially keratinized, partially eroded 
BCC had a good separation between tumor and non-tumor regions allowing the 
successful correlation of the Raman and microscopic data (Fig. 4.2). 
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Figure 4.2 VIS image of a partially keratanized, partially eroded BCC overlaid with the 
Raman measurement (left). K-means cluster spectra showing differences in Raman peaks 
between tumor (red) and normal (black) tissue regions (right). 
 
Between 1450 and 1660 cm-1 there has been an increase in intensity of those spectra 
originating from the tumor region. Moreover, there has been a peak shape difference 
observed with the Amide I band between the spectra obtained from the tumor and 
normal regions. The spectrum from the tumor region has a peak at 1528 cm-1 possibly 
corresponding to the presence of carotenoids and/or chromophores [93]. This has been 
observed to be similar to that observed in spectra on Fig. 4.1. Fig. 4.3 shows the 
difference spectrum of tumor and non-tumor regions.  
 
Figure 4.3: Differnce Raman spectrum of the sample from patient #4. The negative 
region specifies cancer related peaks while the positive is vice versa.  
 
Apart from the sharp peaks at 1004 and 1449 cm-1 there have been broad regions 
identified between 1270 – 1350 cm-1 and 1600 – 1700 cm-1 as those with the most 
CHAPTER 4 Results and discussion- A pilot clinical study 46 
prominent cancer identifying regions. Since the original spectra have been noisy, it 
was challenging to accurately track the changes occurred due to BCC. Considering 
other samples, the difference spectra demonstrated a similar shape mainly at the 
region between 1400 and 1600 cm-1.  
 
A large sample variation was observed from patient-patient as well as sample-sample. 
Since all samples originate from different patients the physiology of the samples was 
different which had reflected strongly on Raman spectra. Many different BCC 
physiologies were measured that made it difficult to find similarities within one 
another. For example, the nodular BCC sample (patient #3, Tab. 4.1) was heavily 
pigmented which produced large amounts of fluorescence that had resulted in a poor 
background correction of the dataset which produced spectra with a lot of noise. On 
the other hand, some samples had no obvious visual differences between cancer and 
healthy tissue (patient #1, Tab.4.1). With the help of OCT imaging the erosion at 
the surface or embedded tumor clusters were discovered.  These were challenging and 
nearly impossible to correlate with the H&E images due to the lack of perfect 
alignment of the former with Raman measurements. Therefore, the number of samples 
measured were too less to be able to correlate the results obtained by the two 
modalities. The most important outcome was that the H&E stains should be at the 
same location and direction of the Raman measurement. Consistency was key to our 
experimental protocol as good correlation was required for comparing the three 
techniques (i.e. OCT, Raman spectroscopy and histopathology) that had been 
addressed. Therefore, as the clinical routine procedures were given first priority, a 
thorough correlation of the data was not possible.  
 
The results from the pilot skin cancer study provided important aspects of measuring 
human skin samples with OCT and Raman spectroscopy. The goal of this study was 
to investigate the characteristics of OCT images and Raman responses of the non-
melanoma skin cancers and to correlate the findings with histopathology, which is 
currently the gold standard. The clinical approach taken by the group of Mahadevan- 
Jansen to differentiate between BCC and normal tissue with a combined OCT-Raman 
spectroscopy instrument, had moving optical parts [33]. In addition, the strategy 
employed involved collecting single spectra from the concerned region and the 
unaffected region. This approach seemingly reduces the efficiency in collection time 
of Raman measurements. By being able to obtain a Raman map from the region of 
interest more representative data can be collected and would provide a better 
overview of the tumor borders. Indeed, the system was not built to obtain confocal 
information but this was a compromise made for this specific application [87].  
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The integration time for each spectrum had been 30 seconds for the previously 
reported combined OCT-Raman setup [33] which had been sufficient to collect Raman 
spectra through the focal axis of the objective lens. However, moving the incident 
laser through many regions of the objective lens to obtain a Raman map would require 
longer integration times, thus the use of 1 second integration time for the mapping 
approach. Due to the time constraints the FOV was kept to a limit even though the 
system could measure a FOV of 10 mm [87].  
 
There had been no mention of the total number of patients that had participated in 
the study but Raman spectral differences from one patient was presented by Patil et 
al. [33]. The largest differences observed were intensity variations at 1090, 1300 and 
1440 cm-1 which seemed to have corresponded to the increase in nuclear material 
compared to the cytoplasm [33]. A similar trend can be observed in the present study 
as well. However, further measurements must be carried out to achieve better 
consistency in data and confirm spectral features associated to tumors. The pilot non-
melanoma skin cancer study had suffered the most with the very small sample 
number. Until now, samples from 18 patients have been measured in this study. 
Another order of magnitude would be necessary to attain statistical consistency. This 
is because when comparing samples from different patients, the complexity of the 
study vastly increases. Moreover, the variety between different cancers would add 
another level of complexity to the dataset. Due to the inconsistency of Raman data 
collected, the data analysis was unique for each sample. However, the difference 
spectra and the Raman k-means data show significant intensity difference between 
cancer and healthy tissue.  
 
A few SCC samples were also investigated which produced overly large fluorescence 
responses masking the actual Raman responses. With some BCC samples a dominant 
fluorescence background was observed that made the data analysis very challenging. 
In contrast, the same amount of fluorescence was not observed with the pork skin 
samples. Therefore, it would be safe to conclude that pork and human skin may have 
similarities, but not exhibit similar inherent fluorescence. It has been found that 
human skin has more vasculature than pig skin and the latter has a larger fat/ lipid 
content [90]. The increased inflammation of the skin may have been responsible for 
the increased fluorescence response in human skin samples. A workaround for inherent 
high fluorescence arising in the combined OCT-Raman setup would be the use of 
1064 nm laser excitation wavelength. For this, an InGaAs CCD must be used as the 
common silicon CCDs would not be sensitive to wavelengths above 1100 nm. In order 
to further improve the system, the Raman spectrometer grating could be exchanged 
to higher number of lines/mm. This would result in accurate wavelength calibration 
with the only disadvantage of having to use longer integration times. If this could be 
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complimented with real time diagnosis based on Raman and OCT images in a clinical 
environment, the advantages would most definitely compensate for the drawbacks. 
 
Collecting spectra from normal tissue regions of patients would have provided more 
insight into the issue of patient-patient variability as well as the high fluorescent 
background as this could possibly be subtracted from the Raman spectra. Without 
an ethical vote for this specific strategy, any in vivo measurements would be 
impossible. The ease and feasibility of obtaining such a vote depends on the country. 
Verisante Aura ™ in the U.S. is a commercially available (FDA approved) setup that 
differentiates melanoma from non-melanoma by conducting a PCA analysis on 
Raman spectra. This setup uses an incident laser source power of  150 mW at 785 
nm central wavelength which was proved not to harm tissue physiology [94].  
 
If OCT were to be accepted as a gold standard, well-trained individuals on extracting 
accurate diagnosis would be in demand. Proving the similarity of OCT and H&E 
stains can be further supported by the dark inclusions on the 2D OCT scans that can 
be observed on the H&E image (Fig. 4.1 C III). This along with the scaly appearance 
and the increase in tissue density support the diagnosis of superficial BCC. The other 
types of BCC had features such as unorganized skin layer morphology which had 
been the hardest to isolate with Raman spectroscopy due to the scattered nodular 
features. The latter observation could be the property for concluding the recurrence 
of a cancer type as vastly scattered tumor granules have been known to reappear [95]. 
Fig. 4.4 further demonstrates the similarity of OCT images with H&E images.  
 
Figure 4.4: A B-Scan of the sample extracted from patient #1 compared with the H&E 
stains obtained from the pathologist. Note: H&E stains have not been sliced at the same 
angle of OCT measurement.  
X 30 
X 100 
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OCT is therefore ideal for visualizing exposed tumors and their cross sections to 
provide morphological information along with their location. There are a few 
commercially available OCT devices for investigating skin cancers, with different 
specifications according to the utilized optical components. Apart from devices used 
for research, those in the market already have successful outcomes. For example, 
Vivosight has been incorporated already into the clinics in New York, U.S.A for 
routine patient consultation. This particular device seems to have a high resolution 
of < 7.5 µm axially and < 5 µm laterally compared with the other commercially 
available devices. Skintell, another device in the market, has a 3 µm resolution both 
axially and laterally but a comparison study conducted showed that it has a lower 
penetration depth and lower signal intensity compared to Vivosight [96]. Another 
group from Vienna has introduced a medical OCT device into the market called 
NITID (11 µm axially and 12 µm laterally) which has been combined with 
dermoscopy.  
 
Overall, the results from the pilot skin study had showed that every sample consisting 
of the same type of tumor vary in terms of composition and physiology. These 
variations were challenging to differentiate due to the inherent fluorescence that did 
not allow the post processing background correction to eliminate the background 
without obscuring signal contributions corresponding to the important Raman bands. 
By identifying the type of BCC relevant therapeutic interventions can be 
implemented. For example, superficial BCC can be intervened by non-surgical 
methods that would not be suitable for other BCC types [97, 98]. Therefore, 
combining both OCT and Raman spectroscopy would benefit patients as well as the 
medical community.   
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4.2 Investigating atherosclerotic plaques 
Concerning the investigation of atherosclerotic plaques both OCT and Raman 
spectroscopy would be advantageous for the cardiologist in diagnosing the stage of 
development. To obtain a first impression of the physiology of plaques ex vivo animal 
arteries containing diet-induced plaques were measured. In total 3 ex vivo samples 
were tested with OCT and Raman spectroscopy, 2 before and 1 after the combination 
of the setup.  
 
Several animal models have been commonly used to investigate atherosclerosis such 
as mouse, rabbit and pig. Many parameters such as similarities to human physiology, 
ease of care and the time frame of plaque formation should be taken into account 
when choosing a suitable model [99]. As one of the first attempts, our research group 
had used a rabbit model for distinguishing plaques in vivo via Raman spectroscopy 
only [85] and the extracted aorta samples from that experiment have been used for 
the current measurements. The main reason for using rabbits as an animal model was 
due to the similarity of the cholesterol uptake and plaque formation pathways to that 
observed in humans [99, 100]. To extend this study, an in vivo animal experiment 
was conducted to achieve direct understanding of the suitability of the systems, data 
quality and the levels of fluorescence.  
 
4.2.1 Evidence before the combination. 
The OCT device used to visualize ex vivo rabbit aortas was a TEL310 (Thorlabs, 
Lübeck, Germany) with an OCTG-1300 scanning apparatus. Initially a region of 
interest (red square, Fig 4.5 A) was selected where a 3D C-scan was carried out (Fig 
4.5 B) with a spacing of 30 × 38 × 7 µm. By changing the contrast post acquisition, 
it was possible to gain a surface image (XZ slice) where the cholesterol deposits appear 
brighter than the rest of the aortal structure. Since atherosclerotic plaque depositions 
exhibit a higher refractive index compared to the connective tissue of normal vessel 
walls of aortas (high scattering cross section), lipid inclusions back reflect more light. 
This had allowed the easy separation between plaques and surrounding by adjusting 
the contrast of the image.  
 
Fig. 4.5 A shows the microscopic image of the aorta section, ~3 cm in length and ~6 
mm in width, cut open along the direction of the blood flow exposing the inner 
surface. It does not provide much information on the topology or any plaque 
formations. The 3D OCT image (Fig 4.5 B) of the entire aorta sample showed the 
rough texture of the inner surface but with no plaque information. By choosing 
specific regions on the aorta, a more detailed visualization was achieved as this had 
increased the resolution of measurements. As can be seen in Fig 4.5 C, the brighter 
CHAPTER 4 Results and discussion- Investigating atherosclerotic plaques 51 
regions could have been early plaque deposits. The penetration depth of the OCT can 
be estimated to be between 1 and 1.5 mm into aortal tissue. Most of the plaques 
locations had a tendency to be at slight bends or ridges of the aortal section as this 
topology would produce a physical barrier against the blood stream promoting easy 
deposition. Thus, the plaque volume seemed to decrease at the edge of the sample 
(away from the bend) compared to the measured region shown on Fig 4.5 C.  
 
 
Figure 4.5: A shows the microscopic white light image of the rabbit aorta and B is the 
corresponding 3D OCT C- scan. C shows three zoomed in sections of the rabbit aorta 
enhancing the surface topology of the top, middle and end.  
 
For the Raman measurement a confocal Raman microscope (WITec alpha300R, Ulm, 
Germany) was used with a 10x objective lens (Nikon 10x, Japan) and the spectral 
results are shown on Fig 4.6.  
 
 
Figure 4.6: A shows the topology of the arterial wall emphasizing the plaque deposits 
with contrast adjustment. B is the Raman spectrum collected from the plaques at the 
position shown in A. The spectrum shows mainly cholesterol contributions.  
 
B A 
A B C 
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The Raman spectrum (1 sec. integration time, 40 mW at the sample) shown in Fig 
4.6 B indicates the presence of lipids and cholesterol at the location where the 
spectrum was collected and this was measured from the red spot shown on the surface 
3D OCT scan (Fig 4.6 A). Spectral bands at 702, 1437 and 1661 cm-1 correspond to 
cholesterol as specified in literature [101]. Since the chemical make-up of plaques is 
complex, the resultant spectrum is a superposition of all the contributions of the 
constituents. Therefore, the pure spectra of cholesterol and lipids would have more 
distinct Raman peaks than observed here.   
 
Table 4.2: Details of the rabbit aorta sample. It had been included in a previous in vivo 
experiment and so anesthesia (ketamine 2-8 mg/kg and xylazine 0.5-1 mg/kg) had been 
administered by intravenous injection during the experiment [85].  
Sample origin Adult male rabbit (New Zealand White, 
Harlan) weighing 3.25- 3.58 kg 
Diet 0.5% cholesterol 
Time period approximate 7-10 weeks 
Fixing procedure 150 ml mixture of 10% hydroxyethyl 
starch and 1% porcine in ratio of 10:1 
followed by a 0.9% saline pressure 
perfusion at 100 mmHg for a period of 
15 mins. The complete aorta was then 
excised and preserved in 5% formalin 
solution. 
 
The diet of the animal had been key to observing the plaque formations and as can 
be seen from the rabbit aorta the plaques had not been fully developed until the 
advanced stage. Therefore, no advanced plaque inclusions were observed but 
superficial spot-like distributions of early plaques. During these ex vivo measurements 
the risk of sample dehydration due to the constant exposure to the laser was 
prominent. At times, a few drops of formalin was added to renew moisture. Moreover, 
any residual blood on the aorta surface had increased the risk of burning the sample. 
Therefore, an optimal laser power must be determined for these experiments. In fresh 
samples, before fixing with formalin, the constituent blood would be still liquid which 
would not harm the samples. The outcomes of the ex vivo rabbit aorta measurements 
have helped the transition to working with ex vivo human aorta samples. 
 
The same measurement strategy was applied to investigate intact ex vivo human 
aorta preserved in 5% formalin. First, a 3D OCT image was collected followed by 
Raman spectra from a position shown in Fig 4.7 A. Here the KAISER RX Raman 
spectrometer was used to collect point spectra (1 second integration time, 40 mW at 
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the sample). To expose the inner surface of the aorta the sample was pinned onto a 
corkboard as it tended to roll to its original cylindrical shape.  
 
Figure 4.7: A shows the bright field image of the inner wall showing the selection for the 
3D OCT scan. B shows the 3D OCT scan. C shows the Raman spectrum of the sample 
showing lipid. 
 
The 3D OCT image (Fig. 4.7 B) do not show any obvious change in contrast at the 
measured location (red spot in Fig. 4.7 A) but there is evidence of lipid deposits as 
depicted by the Raman spectrum (Fig 4.7 C). The Raman band at 1442 cm-1 and 
1660 cm-1 as well as the bands in the lower wavenumber region relate to  the CH2 
bending and C=C stretching vibrations associated with cholesterol, cholesterol esters 
and fatty acids. The band with the highest intensity from 2800 – 3000 cm-1 
corresponds to CH stretching vibrations.  
 
 
Figure 4.8: A shows the bright field image of the inner wall showing the selection to do 
3D scan. B shows the 3D OCT scan. C shows the Raman spectrum of the sample showing 
calcium peak position (red arrow at 950 cm-1). 
 
At another region on the same aorta, the presence of crystalline calcium was obvious 
from the Raman peak at 950 cm-1 (Fig. 4.8 C). The 3D OCT image clearly showed 
the topology of the cavity that was scanned. Calcium deposits have been represented 
as a sheet- like bright layer with OCT, which had been difficult to distinguish from 
the VIS image of the aorta wall. These measurements therefore show the use-case of 
both OCT and Raman spectroscopy. The next section focuses on the combined OCT-
Raman setup to characterize an ex vivo human aorta. 
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4.2.2 Combined OCT-Raman system measurements ex vivo human aorta 
Several aorta positions had been scanned using OCT prior to the Raman imaging 
step. OCT C-scans consisted of a volume of 4 × 4 × 3 mm with a penetration depth 
of 1.5 mm. The OCT image acquisition took less than 10 seconds. Fig. 4.9 shows the 
OCT images of the above-mentioned dimensions and 4.9 A represents a C-scan with 
the noticeable abnormal inclusions indicated by a red arrow. The image has been 
overlaid by the B-scans that were chosen to demonstrate a calcified deposition (Fig. 
4.9 B). The deposit had a diameter of ~ 0.25 mm and approximately 0.5 mm below 
the aorta surface. This is easily comparable with B III where no noticeable inclusions 
had existed. Histopathology images corresponding to the B-scans are shown in Fig. 
4.9 C and the calcium deposit was successfully correlated with the tissue sections. 
This was conducted after OCT-Raman image recording and the image analysis was 
carried out on the software ThorImage OCT and ImageJ software.  
 
Those areas with inclusions (higher refractive index) were chosen for Raman imaging 
which were recorded with resolutions varying from 50 to 100 µm as well as areas 
ranging from 0.25 to 1 mm2. The data acquisition was limited by the step size and 
due to the time constraints smaller areas such as 2 × 2 mm were recorded with Raman 
image acquisitions.  
 
Figure 4.9: OCT images of the aorta area with calcified depositions in comparison with 
histology. A is an OCT C-scan image of a 4	×	4 mm2 area and B are representative B-
scans of the positions indicated in A as I – III. B I and II show calcification, which was 
confirmed by histopathology shown in C. B III does not show significant inclusions. 
Adapted from [102].  
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Raman spectra were background corrected via a SNIP algorithm [89], and area 
normalized. Raman images were generated by the N-FINDR spectral unmixing 
algorithm described by Winter et al.[103, 104] and by a k-means clustering and in 
both cases R software packages were used [105]. These Raman maps have been 
overlaid with a sample C-scan on Fig. 4.10. Another surface C-scan of the sample has 
been shown in Fig 4.11 A and the area with the calcium deposits were located 
approximately 0.5 mm beneath the surface (red square). By adjusting the overall 
contrast of the image, the inclusions were made visible. This region was then 
measured using Raman spectroscopy similar to that of the pilot skin cancer study. 
The dimensions of the Raman images are 1 × 1 mm2 with a step size related resolution 
of 100 µm. Since the sample was already fixed in formalin there had been no time 
constraints for measurements but the sample was tending to dry during longer 
measurement times.  
 
The corresponding Raman spectra from the two algorithms used to produce Raman 
images have been plotted in Fig. 4.11 B - E. They have clearly identified 3 different 
regions within the area of interest indicated by the red square on the 3D OCT image. 
Raman spectra show Raman bands that are typical for proteins, as well as calcium 
phosphate. For the NFINDR algorithm the calcification has been plotted in green 
and for the k-means in red where both exhibit a sharp calcium phosphate peak located 
at 960 cm-1. Calcium phosphate is the main inorganic component found in 
calcifications of the arteries, whereby the scattering intensities are caused due to 
symmetric vibrations of the (O=PO3)2- anionic phosphate. The areas surrounding the 
calcification shown in blue colors are mainly connective tissue, which produce spectra 
with main protein features at 1650 and 1455 cm-1, associated with carbonyl stretches 
of the peptide bonds of the protein backbones and CH2 deformations of the peptide 
residues, respectively. Significant amounts of lipids, such as cholesterol or triglycerides 
could not be observed, which may have been incorporated into the band positions of 
the two mentioned Raman bands generally found at slightly lower wavenumbers 
around 1650 and 1440 cm-1 for lipids. 
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Figure 4.10 Raman maps overlaid over the 3D OCT scan that shows the calcium inclusion 
of the measured human aorta sample. Adapted from [102] 
 
 
 
Figure 4.11: OCT image of the surface C-scan of the plaque is shown in (A). The red 
square shows the region of interest where the Raman maps have been collected. The 
Raman spectra shown in B and C, as well as D and E for a VCA and K-means cluster 
analysis, respectively represent the plaque contituents. Adapted from [102].  
 
The Raman maps have been overlaid with the 3D OCT image, where the top image 
(also shown on Figures 4.11 B & D) reconstructed by the spectral unmixing algorithm 
and the bottom by k-means clustering. The relevant sample details are shown on 
Table. 4.3.  
 
Table 4.3: The sample information of the ex vivo human aorta. The extraction was 
conducted at the Heart Center Freiburg-Bad Krozingen, University of Freiburg, 
Freiburg, Germany [102]. 
Sample origin Human carotid artery plaques donated 
with written consent by patients who 
underwent endarterectomy.  
Fixing procedure 5% para-formaldehyde and stored at 4°C 
Histopathology Samples embedded in Tissuetec® and 
cryo-sectioned using a CM1860 
A 
B C D E 
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cryotome (Leica, Germany) at -20°C, 
into sections of 10 µm.  
 
In both ex vivo human samples lipid signatures had been observed along with very 
intense Raman bands of crystalline calcium (if present). With the second ex vivo 
human aorta the acquired Raman images correlated very well to the calcium rich 
areas identified by OCT. The penetration depth of the Raman scans was undoubtedly 
enough to record spectra with a good signal-to–noise ratio. Differentiation of 
crystalline calcium deposits from the surrounding connective tissue was possible with 
the chemically specific Raman spectroscopy. One observation that is important to 
mention is that areas with high abundances of coagulated blood did not give any 
measurable Raman signal, but showed strong fluorescence backgrounds, which was 
not surprising because of the presence of chromophores. After the investigations with 
ex vivo samples an in vivo investigation was implemented using an animal model and 
the following section discusses its experimental details.  
 
4.2.3 In vivo plaque investigation 
It has been shown with the outcomes of the ex vivo samples in previous sections that 
plaque characterization with the combined OCT-Raman setup is in fact feasible. 
However, before the introduction of a novel device into the clinics it must be tested 
on an animal model in vivo to address unexpected issues. In order to enable such an 
investigation a special fiber probe must be developed combining both OCT and 
Raman spectroscopy which can reach the arteries. As a preliminary step to the 
catheter fiber probe, the ability to correlate OCT and Raman data collected in real 
surgical conditions was tested using separate systems.  
 
For surgical conditions, all devices must be able to withstand the standard sterilizing 
procedure. If the function of the optical components were to degrade over time due 
to the use of ethanol, the entire design of the system must be changed to suit clinical 
requirements. Moreover, there is a large probability that the presence of blood in 
arteries could result in producing large amounts of fluorescence that might obscure 
the Raman signals. The same goes for the contrast agent used in OCT imaging that 
flushes the arteries temporarily before measurement. Unless tested these points are 
challenging to predict and would carry the risk of interfering with the Raman signals 
leading to false outcomes. Therefore in vivo animal tests with the two modalities are 
necessary.  
 
For this endeavor, an external OCT system was used along with a clinically approved 
catheter probe. The details of the OCT instrument is shown on Table 4.4. 
CHAPTER 4 Results and discussion- Investigating atherosclerotic plaques 58 
 
 
 
Table 4.4: OCT instrumentation of ILUMIEN™ Optis™ system (St. Jude Medical, 
US) for in vivo investigation of plaques 
Type of OCT and source wavelength Swept source at 1305 ± 55 nm  
Power  26 mW 
A-scan depth in air 7 mm 
A-scan depth in contrast agent 4.83 mm 
Scan repetition rate 90 kHz 
Frame rate 180 images per second 
Catheter used C7 Dragonfly (St. Jude Medical, US) 
 
The contrast agent was required to allow better contrast and it was administered 
before OCT imaging manually into the side port of the imaging catheter. During the 
experiment the OCT probe was inserted through a 6F introducer (B. Braun, 
Melsungen, Germany) that was attached to a guidewire (Terumo, Tokyo, Japan).  
Once the contrast agent had been introduced the device software had initiated the 
pullback process which measured a length of 40 mm. This pullback technique enabled 
the imaging of the entire circumference of the vessel. The probe was essentially pulled 
backwards at a constant speed from a certain location where plaques were suspected 
to occur. During the pullback, the cross-sectional recording of the aorta took place in 
a helical fashion. This rotating movement had been achieved by a microcontroller 
implemented into the commercial OCT system only. All data were reviewed later 
with the help of the cardiologist.   
 
Raman fiber probe used in this study had been successfully utilized in a previous in 
vivo rabbit experiment within our working group [85]. The Raman setup and fiber 
information are shown in Table 4.5.  
 
Table 4.5: Raman spectrometer and fiber probe details.  
Raman spectrometer RXN1 spectrometer (Kaiser optical 
systems, USA) 
Fiber probe Multi-mode (MM) excitation waveguide 
of 100 µm diameter surrounded by 12 
MM collection fibers; diameter of 125 
µm. (EM Vision, Loxahatchee, FL, 
USA) 
Total diameter  1 mm (after the steel guided tube) 
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Incident laser source Invictus MM cw laser with an FC/PC 
coupling at 785 nm with 100 mW fiber 
coupled power 
Integration time 1 – 10 second 
 
The fiber probe was embedded at the front with edge filters to avoid any excitation 
light entering the collection fibers. The fiber probe was designed as a forward facing 
even though a side-viewing probe would have been more appropriate. In fact, the in-
house side-viewing fiber probe that was scheduled for the experiment was too large 
that there was too less space for the fiber probe to move along the rabbit aorta. It 
would have eventually caused ruptures and damage the aorta wall. To meet the 
requirements of the SMA input of the excitation path connector, an SMA – FC/PC 
adapter was used. At the output of the probe, the twelve collection waveguides were 
stacked in one line around the SMA connector so that the CCD would essentially 
detect a vertical line coupling the back scattered Raman response. Binning was 
adjusted to minimize CCD noise and background effects. A spectrometer wavelength 
calibration, as well as an intensity correction for changing quantum efficiencies of the 
CCD was carried out after moving the spectrometer to the clinic. The laser 
wavelength was calibrated by cyclohexane after the CCD cooling procedure directly 
before surgery. The whole system was set on a mobile tabletop to enable flexibility 
during the entire process.  
 
The animal experiment involved rabbits with induced-plaques and the details of the 
animal and fixing process has been listen in Table 4.6.  
 
Table 4.6: Details of the animal, diet and the fixing procedure for the in vivo 
measurements  
Animal Male rabbit (New Zealand White, 
Harlan) weighing approximately 3kg. 
Diet 0.5% cholesterol 
Time period approximate 7-10 weeks 
Fixing procedure 150 ml mixture of 10% hydroxyethyl 
starch (Fresenius Kabi Deutschland 
GmbH, Bad Homburg, Germany) and 
1% porcine in ratio of 10:1 followed by a 
0.9% saline (Fresenius Kabi Deutschland 
GmbH, Bad Homburg, Germany) 
pressure perfusion at 100 mmHg for a 
period of 15 mins. The complete aorta 
was then excised and preserved in 5% 
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formalin solution (Oscar Fischer GmbH, 
Saarbrücken, Germany) solution. 
 
The rabbits were anaesthetized via an ear vein intravenously using ketamine 2-8 
mg/kg (Ketamin “Gräub” 10%, Albrecht, Aulendorf; Germany) and xylazine 0.5-1 
mg/kg (Rompun Trockensubstanz, Bayer, Leverkusen, Germany). A 6F introducer 
(B. Braun, Melsungen, Germany) was inserted through a small arterial cut, followed 
by the insertion of a guidewire (Terumo, Tokyo, Japan), which was inserted into the 
descending aorta. Then for image with OCT through a 6F catheter (Cordis, 
Langenfeld, Germany) the contrast medium (Visipaque, GE Healthcare Buchler, 
München, Germany) was introduced to obtain an angiogram of the complete aorta. 
Throughout the entire experiment angiography was enabled to localize fiber probes. 
There had been concerns that the contrast agent would harm the animal which 
resulted in swapping the imaging order i.e. first Raman measurements were conducted 
and then the OCT scanning. The measurements were carried out one after the other 
such that first the Raman –probe was inserted assisted by the catheter until the aortic 
bifurcation and slowly retracted manually collecting Raman data on suspicious lipid 
depositions. The Raman measurements has begun at the abdominal aorta and 
proceeded to collect from thoracic and aortic arch. Single point spectra were collected 
between 1 – 3 seconds integration time and approximately at every 0.5 cm. 
Subsequently, the Dragonfly catheter was introduced after withdrawing the Raman 
probe and several scans were measured along the entire length the aorta. At the end 
of the measurements the animal was sacrificed and the aorta fixation procedure as 
mentioned in Table 4.6 was followed.  
 
The outcome of this experiment for characterizing aorta was that the aorta was 
normal with sightings of early plaque formations at a few positions. The relevant 
OCT images are shown in Fig. 4.12 picked from the image dataset which also show 
the Dragonfly OCT probe. These cross-sectional OCT images were collected from the 
thoracic aorta and the most distinctive features observed were the rough slightly 
bulging formations on the inner vessel wall (white arrows in Fig. 4.12). Here, the 
importance of the penetration depth achieved by the system can be displayed by the 
fact that the entire circumference of the aorta was imaged even though the probe 
placement was at the one end of the vessel (diameter ~ 3.5 mm). The depth visible 
on the aorta wall was ~ 0.75 cm and the deformations were a few 100 µm in size.  
CHAPTER 4 Results and discussion- Investigating atherosclerotic plaques 61 
 
Figure 4.12: OCT images of one of the rabbit aortas investigated for characterizing 
plaques in vivo. The white arrows show the locations of early plaque formations. 
 
Apart from cross-sectional images, the pullback imaging method had produced an 
entire optical cut along the blood flow of the measured aorta (Fig. 4.13).  
 
 
Figure 4.13: OCT cross-sectional image across the blood flow of the thoracic aorta. The 
positions marked A,B and C correspond to that shown in Fig. 4.12. The units of the scale 
are in mm.  
 
The entire length measured was about 3 cm, minus the image obscured either by the 
heartbeat of the rabbit or the OCT probe reaching the end of the catheter. On the 
other hand, the collected Raman spectra had produced characteristic bands related 
to lipids mainly. Collagen signatures were also observed as the vessels contain 
connective tissue. This resulted in protein and cholesterol related spectral features 
being detected in the Raman dataset. Signs of lipid deposits had appeared in the 
upper part of the aorta close to the heart. This can be seen from the spectra shown 
in Figure 4.14.  
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Figure 4.14: Raman spectra from an aorta position that do not contain plaque depositions 
(A) and that with lipid depositions (B).  
 
The spectrum A (Fig 4.14) shows the typical Raman bands of proteins that relate to 
the protein/collagen from the arterial wall whereas the spectrum below displays lipid 
features. The peak at 2855 cm-1 has been associated to CH2 symmetric stretching [106] 
and therefore shows the presence of lipids. In general, the shape between the spectral 
region between 2800 and 3000 cm-1 contains a difference. In the lower spectral regions, 
peaks at 1269 (C-H symmetric rock- cis) [106] and 1299 (triacylglycerol) [107] can be 
observed.  
 
The extracted thoracic aorta was dissected for histopathological inspection. An elastic 
van Gieson (EvG) stain was applied to emphasize the microscopic features and this 
was compared with the OCT and Raman data. Fig. 4.15 shows the comparison 
between the OCT B-Scan and the EvG stain obtained from the same location as the 
OCT image. The alignment of data locations were not precise due to the slight change 
in protocol i.e. utilizing Raman spectroscopy prior to OCT imaging. As Fig. 4.15 B 
suggests the intima had been swollen compared to the rest of the tissue circumference. 
Since OCT would provide the most natural image of the intact aorta compared to 
the histopathology, the swelling had not been very prominent at the region 
emphasized (white box). The stained image shows spaces between the tissues that 
can be concluded to be lipid deposits.  
 
A 
B 
CHAPTER 4 Results and discussion- Investigating atherosclerotic plaques 63 
 
Figure 4.15: OCT image with an inset showing the entire cicumference of the aorta (A) 
from the extracted part shown in figure 4.13. (B) is an an EvG stain of a section from 
the same region (L  lumen or artery, M  muscularis media and A  adventitia).  
 
Comparing the morphological information with the spectroscopic features, Raman 
bands have highlighted the presence of lipid build up at the regions of the aorta.  
 
 
Figure 4.16: The spectrum on (A) has been taken from the location shown in image (B) 
which an X-ray image is taken during the experiment. The position of the Raman probe 
can be seen as a dark line adjacent to the bottom of the image.  
 
The trend in Raman bands are similar to that shown in Fig. 4.14.  
 
Table 4.7: The assignments of the observed Raman band in Fig. 4.16 
2850 cm-1 Symmetric methyl stretches 
1640 cm-1 C=C stretching of unsaturated 
1440 cm-1 CH2 scissoring 
1150 – 1300 cm-1 CH deformations- saturated and 
unsaturated fat 
A B 
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At lower wavenumber regions the quartz fiber probe had produced background that 
had not allowed the successful extraction of Raman spectra. Considering the overall 
spectral shape, triglycerides have been the main ingredient of plaques measured in 
this experiment. Previous results have also shown that plaque depositions have been 
dominated by cholesterol, cholesterol esters as well as accumulations of triglycerides 
[47, 108]. Hence, the combination of an OCT-Raman microscopy setup, which can 
operate in imaging mode, have clearly identified areas of calcification as well as the 
presence of lipids within an arterial wall affected by atherosclerosis.  
 
This chapter has documented the experimental results from individual systems as 
well as the combined modalities. Opting for measurements with separate systems in 
the case for both ex and in vivo, had assisted the preliminary assessment of spectral 
quality and issues related to the methodology. In general, plaques from animals had 
not shown the expected amounts of plaque formations either due to low 
concentrations of cholesterol or simply less consumption. The OCT scans had 
delivered very clear images of the morphology of the atherosclerotic inclusions as well 
as surrounding tissue. For early plaques just using OCT did not show a large 
difference in contrast between the surrounding area and lipid inclusions. From the 
Raman spectral analysis the achieved sensitivities were enough to detect early plaque 
formations. The obtained data quality was sufficient to assign the major plaque 
constituents as triglycerides reflecting the cholesterol enriched diet. The experimental 
strategy involved applying several seconds of non-focused laser illumination at 100 
mW within the artery that had not lead to any noticeable alterations of the walls of 
the blood vessels, as confirmed by subsequent histopathological staining. For the 
current setup for an excitation wavelength of 785 nm, the time frame of 1 s per 
spectrum at a laser power of ~ 100 mW at the laser focus was comparable to similar 
experiments previously reported and potentially applicable to in vivo conditions [108-
110]. Thus, the combination of both modalities is required to arrive to a conclusion 
when dealing with early stage plaques. Moreover, the in vivo measurement 
emphasized the feasibility of this technique and using both information from OCT 
and Raman are vital for diagnostic decisions.  
 
To conduct a more thorough investigation on identifying different stages of plaque 
development, more samples are necessary so that the morphological features and 
spectroscopic signatures can be identified for each type. This would eventually result 
in reduced false positives and would lead to more diagnostic standardizations. The 
amount of stress induced by this dual approach is still very high. Containing two 
modalities in one device would result in the collection of twice the amount of valuable 
information in one attempt compared to a diagnosis confirmed by a single method. 
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This would drastically reduce the amount of surgeries the patients would have to 
undergo. Moreover, by the knowledge acquired through exhaustive measurements, 
the cardiologist would be able to estimate the stage of the plaque and prescribe more 
effective therapeutic measures at an earlier time point. Not only for plaque 
characterization but also the possible treatments such as balloon angioplasty or stent 
implantation can be monitored by this combined imaging method. Second-generation 
balloons for angioplasty and stents, which have been coated with drugs to prevent 
early restenosis, are currently under development [111-113]. The efficiency of such 
drug coated balloons and drug eluting stents can be investigated by monitoring the 
concentration and long term release spectroscopically, as the active compounds would 
exhibit distinct spectral bands [114, 115].  
 
As for next steps, an OCT fiber probe was developed for the inclusion of Raman 
modality so that the in vivo atherosclerotic characterization would be enabled. The 
following chapter presents the details of the OCT fiber probe development for future 
combination with Raman spectroscopy. 
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5 Fiber approach 
The venture to have non-invasive medical devices that could reach inner organs to 
expose the disease-causing agent is still under way. Especially with atherosclerosis 
this has become one of the main points to influence the development of a flexible fiber 
probe that can access the arteries where plaque formations are located. This fiber 
probe can further be applied in characterizing skin cancers to investigate depth 
infiltration. The combination of OCT and Raman spectroscopy for characterizing 
plaques the imaging probe head would need to be miniaturized into a fiber probe that 
it can access the aortas via a small incision. This would in the end obtain both 
morphological and spectroscopic information that would lead to better diagnosis. The 
following sections present the OCT fiber probe development and the future next step 
would be to include the Raman modality. For this venture, we had collaborated with 
OBEL labs at the University of Western Australia (UWA) which pioneers in fiber 
OCT development for clinical application such as imaging breast cancer [51] and deep 
skeletal muscles [116]. For the measurements with this OCT fiber probe a special 
sample holder was designed and produced. The fiber probe was later characterized to 
obtain the spot size and other properties in terms of performance. A similar setup 
was built at the Leibniz Institute of Photonic Technology (IPHT) which was able to 
couple with the SD-OCT system that had been introduced previously. 
 
5.1 Sample holder 
A sample holder for OCT fiber probe measurements was required due to the 
properties of the sample itself as well as the experimental strategy. The samples 
described in section 4.2.1 were used again where the aorta section was cut 
perpendicular to the axis into three ~15 ×15 mm samples. These aorta samples had 
a tendency to roll up due to its natural cylindrical shape and elasticity. To prevent 
this from occurring an in-house sample holder was designed using SolidWorks (Fig. 
5.1, left) which was then produced using a 3D printer. The circular opening of the 
top cover measured up to a diameter of 16 mm (Fig. 5.1, right) which was protected 
by a quartz slide. The quartz cover was fastened onto the top part of the sample 
holder by using UV adhesive. This type of glue was chosen as it would not contain 
organic components that would have potentially interact with the samples. The 
quartz window had been implemented so that the sample would be protected from 
any collisions that might occur between the fiber probe and the sample. It further 
flattens the sample enabling easier scanning. The base of the holder consists of a 
raised stage-like protrusion where the sample would be usually placed. The gutter-
like structure around this stage was designed to hold any extra liquid introduced onto 
the samples for maintaining appropriate moisture levels. With the help of four plastic 
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screws the top cover can be secured to the bottom part along with the aorta sample 
in between. This sample holder prevents the sample from losing its moisture during 
measurement and it efficiently keeps the aorta open exposing the inner arterial wall. 
The amount of stress applied during fixing the two parts must be minimal as the 
quartz window had shattered a few times.  
 
 
Figure 5.1: Sample holder design sketch (SolidWorks, left) and the 3D printed product 
showing its dimensions (right). 
 
The bottom half of the holder has extra material printed, similar to a stand, so that 
a tiltable stage would be able to maintain a stable grip. 
 
5.2 Needle probe 
The development of a needle probe specifically for medical applications was intended 
to minimize the invasiveness of the entire investigation. In the clinic this would be 
suitable for a point-of-care imaging modality [117]. Even though the procedure is 
identified as a minor surgery the incision would be relatively small. For intravascular 
applications needles cannot be used but this was the closest approximation to the 
necessary miniaturized geometry and the needle was used as a casing to protect the 
fiber and to provide rigidity during experiments.    
 
Initially, an ABCD Matrix [118] was utilized to simulate and explore the feasibility 
of the OCT fiber probe that would fulfill the required parameters such as the focus 
spot size, beam diameter and working distance. Then the proposed enface needle 
probe was developed which consisted of a stretch of single mode fiber (SMF) that had 
transported light from the base unit. A length of 345 µm no- core fiber (NCF) with 
a diameter of 120 µm had dispersed the light beam which focused onto the sample 
using a gradient- index (GRIN) lens with a length of 108 µm (Fig. 6.25). After splicing 
these crucial parts together, the fiber was then inserted into a 690 µm needle after 
the head of the needle was sanded down. The casing by a needle was carried out to 
give the probe some rigidity and for easy handling. By introducing a blunt tip, the 
fiber probe would be able to reach the surface of the quartz sample holder window. 
52 mm 
16 mm 
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It further protects the user from accidentally poking himself. In the case of skin cancer 
diagnosis the needle would need to be sharp in order to penetrate through tissue to 
obtain depth imaging for example. Index matching liquid (NA = 1.5) were used 
between the quartz window and the fiber tip to reduce artefacts. The resulting NA 
of the fiber was 0.048. 
 
 
Figure 5.2: The schematic of the needle probe (top) and image (bottom) 
 
The working distance or the focal length of the OCT fiber probe was 380 µm in air 
(513 µm with a 	 = 1.35 i.e. the average refractive index of water and tissue) and 
the focal spot diameter was measured to be 20 µm. These resultant parameters were 
very close to the parameters specified for the simulation (575 µm working distance 
and 17.4 µm spot size). The uniformity of the beam profile can be observed in Fig. 
5.3.  
 
Figure 5.3: Beam profile in terms of an intensity map across XZ (left) and YZ (right) 
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axes. The colour index of black to blue relates to highest to lowest intensity detected 
respectively. 
 
The beam intensities are uniform in both XZ and XY axes deeming it suitable to test 
on the aorta sample. In case, the beam intensity outputs were not symmetric and the 
parameters out of specification the fiber probe would have been redeveloped.  
 
Figure 5.4:  The change in beam diameter (left) and the on-axis intensity profile (right) 
throughout the probe  
 
Fig. 5.4 further demonstrates the behavior of the beam where it can be approximated 
by a Gaussian profile, which was also assumed by the simulations. Since the intensity 
curve in both x and y are maintaining a good overlap, it was further confirmation 
that the beam was symmetric with a focus at 380 µm in air. The focal spot diameter 
was 20 µm.  
 
5.3 SS-OCT fiber system 
The measurement setup at OBEL labs was a swept source OCT (SS OCT) system 
with a bandwidth of 100 nm, centered at a principle wavelength of 1310 nm.  
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Figure 5.5: Schematic of the 1310 nm SS- OCT system coupled with the needle imaging 
fiber. (Modified and adapted from [116]) 
 
The basic working principle of the SS-OCT is that a tunable laser with a specific 
bandwidth consisting of narrow separated spectral lines would scan across the sample 
and provide an image after being Fourier transformed [119]. This method of producing 
cross-sectional images do not require the use of a spectrograph. The trigger pulses (50 
kHz) were synchronized with the needle motion controller along with the signal 
acquisition such that after every trigger from the laser a signal would be recorded. A 
Mach-Zehnder interferometer (MZI) clock output of the source had been achieved 
that allowed time gated sampling in terms of frequency. The power input and output 
was monitored via power meters at the reference arm and free fiber ports where the 
light intensity split was taking place via beam splitters. As shown by the diagram the 
laser output signal had been split by a coupler where 90% of the input power was 
sent to the interferometer by a circulator. The other 10% was directed to a balanced 
detector that subtracted this signal from the returned interferometer response. This 
had enhanced the SNR and any laser fluctuations. The variable optical attenuator 
(VOA) had equalized the intensity levels between the interferometer and the laser 
power signal, which was necessary for a correct signal subtraction. The detector used 
was an InGaAs AC coupled photodetector.  
 
For the measurements the sample holder was fixed to a moving stage and the need 
probe was positioned enface for the scanning process.  
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Figure 5.6: The placement of the aorta sample on the sample holder and mounted on a 
moving stage which is coupled with the source trigger. The needle probe is positioned on 
top using a holder. 
 
A lot of care had been taken not to crash the needle probe onto the quartz window 
which might not only damage the needle probe but also the sample holder. 
 
5.4 Application of the OCT needle probe on ex vivo rabbit aorta 
The measurement process involved choosing a relevant scan area in terms of inserting 
x and y coordinates onto a custom-built software that had been developed to control 
the stage. Then an appropriate step size was chosen that would fit the laser spot size 
and the sample in question to achieve the desired imaging resolution. It was very 
important to align the stage so that any collisions between the fiber probe and the 
quartz window would be avoided. Index matching liquid (n=1.5) was applied between 
the fiber tip and the quartz surface to avoid harsh back reflections due to the change 
in refractive indices. At each step an A-scan would be collected and after the entire 
measurement the recorded A-scans were converted to B-scans by averaging 2 A-scans. 
The depth range achieved was 5 mm and therefore in a medium with n=1.35 (usual 
tissue refractive index) the achieved axial pixel size was 5.04 µm. 
 
To enhance the image quality an apodization window (Hann), was used to reduce the 
side lobes of the axial point spread function before signal processing. Fig. 5.7 shows 
the steps in spectral processing where the apodization can be clearly seen.  
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Figure 5.7: Steps of signal processing in fiber OCT and the interpretation of the signals 
observed. 
 
After the Fourier transform, respective peaks of the sample as well as the reflections 
from the GRIN interface can be observed. The term referred to as “sample from 
common path” has been the sample signal observed after it has been reflected and 
superposed /interfered with the back reflected incident signal. Here the GRIN surface 
would act as a mirror that reflects the incident signal back into the fiber probe.  This 
observation has resulted in utilizing this back reflected signal as the reference signal 
omitting an extra reference arm (common path). The reference signal produced by 
the common path is still independent from the sample. The sample arm had received 
a power of 32.4 mW.  
 
As the Fig. 5.8 shows a 3D construction of the scanned rabbit aorta had displayed 
the rough surface structure that had been detected with the microscopic setup 
previously. The sample had been cut along the blood flow and flattened between the 
top and bottom of the sample holder which had resulted in the bright patchy regions 
on the 3D OCT image. Since these aortas had early plaque formations the cross 
sections did not show obvious plaque features besides small bumps as seen during the 
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in vivo animal experiments. The slight shadowing also suggests that the uneven 
topography indeed relate to plaque formations [80]. 
 
 
 
 
Figure 5.8: Top: 3D constructed image of a rabbit aorta measured with the SS-OCT and 
the needle probe. It consisted of 10.5 x 7 mm FOV with a resolution of 5x10 um across 
the corresponding axes. The laser power used was 200 mV at the reference and 1V range. 
Bottom: a B-scan demostrating the features on the aorta surface. The red arrow shows 
a small bump that represent lipid accumulation.  
 
The results presented in the previous section have provided a detailed overview about 
the experiments performed in order to test the implementation and application of the 
OCT needle fiber probe on excised rabbit aortas. The main aim of this venture was 
to test the feasibility of miniaturizing the OCT-Raman system. Even though the 
Raman counterpart is pending, the OCT needle-fiber probe has produced promising 
results given that this had been the first attempt to image aortas. Similar to previous 
applications, more samples at different plaque development stages would be useful to 
provide a deeper insight into the capabilities of the needle probe. For further in vivo 
application the needle casing must be replaced with a material that is more flexible 
for easy passage through aortas. This would essentially reduce the invasiveness of the 
diagnostic surgeries and cardiologists would be able to extract more information. 
 
One issue that may arise in an in vivo application would be the heartbeat of the 
patient interfering with the measurement. As a solution, Wang et al. had investigated 
the possibility of synchronizing with the heartbeat, which involved faster data 
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recording [120-122]. By including Raman into this application, more chemical 
information can be obtained during the surgery.  
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6 Summary 
The implementation of a combined OCT-Raman device has been presented along 
with its systematic characterization to assess performance and suitability for the 
measurements of biological samples important for medical diagnosis. With the main 
focus on non-melanoma skin cancer and atherosclerotic plaque investigations both 
OCT and Raman spectroscopy results were compared with histopathology which is 
the gold standard since many years. By correlating the results, it can be concluded 
that the combined device was able to differentiate between diseased and unaffected 
tissue. In an attempt to miniaturize the microscopic setup an OCT needle-fiber probe 
was developed with future expectations to combine with Raman spectroscopy. 
 
The combination of the two modalities in the microscopy-based system takes place 
via dichroic mirrors placed strategically within an optical probe cage. The general 
measuring workflow consisted of OCT providing cross-sectional images of the samples 
followed by a Raman map of concerned areas to identify the constituents. The former 
enables quick morphological visualization of any concealed abnormalities beneath the 
surface that had assisted the latter analytical method to provide subsequent 
diagnostic information due to its high chemical specificity. The advantage of having 
two modalities consists of extracting more information in one diagnostic step that 
would definitely reduce the chain of laborious efforts required to carry out a fast and 
successful diagnosis. This will not only influence faster diagnosis but also reduce the 
number of surgeries which would lead to reduced risks of infection. Advantages and 
disadvantages of the combined setup have been summarized in Table 6.1.  
 
Table 6.1 Summary of advantages and disadvantages of the combined OCT-Raman 
spectroscopy system.  
Type of application  
in vivo 
OCT- Raman 
Advantages  Disadvantages 
Non melanoma skin 
cancer differentiation 
Both morphological and chemical 
data extracted 
Optical equipment must fit both 
modalities 
Reduced number of surgeries by 
eliminating follow-up biopsies 
Presence of high fluorescence 
masking Raman signal 
Ability to differentiate the border 
between diseased and healthy 
tissue 
Raman laser power must be 
regulated 
Atherosclerotic plaque 
identification 
Same as above Need to use contrast agents and 
X-ray imaging 
Plaque vulnerability confirmed 
via two modalities 
Invasive 
Reduced risk of infections  
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The OCT-Raman device demonstrated sufficient axial and lateral resolution (OCT- 
10 µm and 13 µm, Raman spectroscopy- ~700 -1000 µm and ~105 µm) to identify the 
diseased from normal tissue. The most challenging task during the device 
implementation was the choice of objective lens. A total of 5 objective lenses were 
extensively tested on a standard as well as commercially available pork loin samples. 
This provided a preliminary overview of the spectral quality as well as the extent of 
the fluorescent background. Since the objective lens finalized for this combination 
was already a compromise, a better substitute would improve the spectral quality 
and would even be able to reduce the necessary laser power influencing the acceptance 
of such a device in medical industry. If the device were to be miniaturized in the form 
of a fiber probe, the issue with the objective lens will be resolved. This solution would 
be beneficial in both medical applications. 
 
From the pilot non-melanoma skin cancer study valuable knowledge of the different 
skin cancer types was attained. Due to the large number of BCCs encountered during 
the clinical trial the final data analysis had a main focus on this specific type of 
tumor. The OCT B-scans of BCC samples showed a significant correlation with the 
H&E stained tissue sections. The accuracy of data correlation was limited by the 
inability to correlate OCT images with histopathology one-to-one due to standard 
hospital procedures. However, the OCT cross-sectional information coupled with 
Raman spectra is valuable in terms of extracting more information through a single 
measurement. A couple of SCC samples that were measured had produced larger 
fluorescence responses compared to that of BCCs that disabled the extraction of 
Raman responses.  
 
A common limitation throughout the experiments was the lack of a large sample size. 
The pool of patients included in this study were reduced from 18 to 7 because of the 
system change that had taken place in an attempt to improve the collection efficiency 
which in fact enhanced the fluorescence response such that any Raman responses were 
obscured. From the 7 patients that were considered for this study, a trend in spectral 
shape was discovered that were consistent within the 7 BCC samples. A larger sample 
size would be necessary to run a successful classification model as well as a training 
dataset to enable the prediction of cancer and non-cancer regions accurately. 
Assuming large number of samples, a PLS-LDA algorithm would be suitable to 
predict the tumor borders in tissue. This would require a careful assessment of 
different types of BCC variations. As a future step, results from a large dataset could 
be used to create a database that directly assists the classification of tumor types in 
patients. In order to achieve reduced fluorescence counts and thus reduced noise 
levels, working in a longer wavelength range such as 1064 nm would be beneficial. 
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Even though this would produce longer integration times, clinical application would 
be still feasible with a ‘live diagnosis’ feature as a future implementation. Integrating 
the device onto a medical cart enabled mobility in clinics. The neat use of light-
blocking material further shielded the Raman spectrometer and the probe head from 
stray light, which would have disturbed the Raman response. The system software 
fulfilled all the user requirements but further improvements would be necessary in 
terms of user friendliness. For future clinical applications the software must be revised 
and coupled with a robust algorithm that extends the current functionality to display 
the diagnosis along with a confidence level.  
 
Atherosclerotic plaque imaging with the combined OCT-Raman setup was only 
focusing on ex vivo samples. Even though an initial overview of early plaques were 
provided by animal aortas, the advanced plaques were human samples. Since early 
plaques show no symptoms and carry a low rupture risk, an account of extensive 
investigations with human samples are limited. Once in the advanced stages invasive 
measures would then be advised to avoid stenosis. From existing literature, a fair 
understanding can been obtained regarding human plaque diagnosis via OCT [40, 80, 
82, 123]. The main feature that had been observed in this study was the absence in 
detected OCT intensity where lipids or calcium deposits were present compared to 
that of unaffected tissue. Furthermore, the perfectly circular lumen had appeared 
deformed with swellings or erosions. When investigating in vivo atherosclerotic 
plaques (animal), the images obtained by OCT had a high probability to carry motion 
artefacts of breathing and heartbeat. To overcome such distortions a research group 
in the Netherlands had imaged coronary arteries within one cardiac cycle by 
implementing a fast OCT pullback method [120]. Thus, combining Raman 
spectroscopy with such a technique would enable a complete plaque diagnosis. The 
Raman spectra of the ex vivo rabbit samples showed evidence of cholesterol (702, 
1437 and 1661 cm-1) whereas human ex vivo samples did not show triglycerides but 
lipids (1442, 1660 and 2800 - 3000 cm-1), calcium (960 cm-1) and protein (1455-1650 
cm-1). Interpreting Raman spectra of aortas had required a thorough understanding 
of the plaque formation at a molecular level. To obtain a deeper understanding of the 
metabolic processes and the storage mechanisms of lipids in cells, Stiebing et al [124, 
125] have investigated these processes via cellular incubation. However, at 
macroscopic levels these molecular features may not be present due to the complexity 
of organic tissue. The amount of observed fluorescence had drastically increased when 
measuring coagulated blood which also had a tendency to overheat. Therefore, for 
future steps, fresh samples without fixing in formalin would be recommended. The in 
vivo measurements lead to characterizing early plaques that provided evidence of 
device-suitability to this specific application. OCT and Raman spectroscopy both 
confirmed the presence of lipids.  
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For the application of the combined system in clinical conditions, an OCT-Raman 
fiber probe would be vital to reach into the arterial locations. The OCT fiber probe 
developed, had produced very clear B- and C-scans and conformed to the desired 
measuring parameters such as working distance, shape of the laser spot and 
resolution. However, to confirm this OCT fiber probe to be suitable for clinical 
measurements, more samples with different plaque stages should be investigated. 
Once the OCT-Raman fiber probe has been developed the measurement strategy can 
be further characterized for its suitability for in vivo measurements. With a Raman-
free contrast agent, the usual workflow can be followed i.e. first imaging with OCT 
and then measuring concerned areas with Raman spectroscopy to identify the plaque 
contents. Compared with the current methods of diagnosis, faster and more efficient 
ways are vital as atherosclerosis could persist without showing symptoms until later 
stages. Potentially the developed needle probe can be applied in skin cancer imaging 
similar to that used for investigating breast cancer [51] that would enable more 
accurate differentiation of cancer borders in all directions. This, however, would not 
maintain the non-invasive criteria. Due to the difficulty and reluctance of welcoming 
novel technologies into the routine diagnostic workflow, it would take a few years to 
witness a large change in the medical industry. Given the increased interest in point-
of-care devices [126], regulatory bodies could include the active testing of novel 
medical devices in order to obtain further knowledge of diseases and elevate the 
chances of recovery by early detection. 
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Zusammenfassung 
Die Implementierung eines kombinierten OCT-Raman-Geräts wurde, zusammen mit 
seiner systematischen Charakterisierung zur Beurteilung der Leistung und Eignung 
für die Messungen von medizinisch-relevanten biologischen Proben, vorgestellt. Mit 
dem Schwerpunkt auf Nicht-Melanom-Hautkrebs und atherosklerotischen Plaque 
wurden sowohl OCT- als auch Raman-Spektroskopie-Ergebnisse mit der 
Histopathologie verglichen, die seit vielen Jahren der Goldstandard ist. Durch die 
Korrelation der Ergebnisse kann geschlussfolgert werden, dass das kombinierte Gerät 
in der Lage war, zwischen erkranktem und nicht betroffenem Gewebe zu 
unterscheiden. In einem Versuch, den mikroskopischen Aufbau zu miniaturisieren, 
wurde eine OCT-Nadelfasersonde entwickelt, die in Zukunft mit Raman-
Spektroskopie kombiniert werden soll. 
 
Die Kombination der beiden Modalitäten im Mikroskopiesystem erfolgt über 
dichroitische Spiegel, die strategisch in einem optischen Sondenaufbau platziert sind. 
Der allgemeine Messablauf bestand aus OCT-Scans, die Querschnittsbilder der 
Proben lieferten, gefolgt von Raman-Abbildungen der betroffenen Bereiche, um die 
Bestandteile zu identifizieren. Erstere ermöglichen eine schnelle morphologische 
Visualisierung von verborgenen Abnormitäten unterhalb der Oberfläche. Dies half der 
letzteren analytischen Methode, aufgrund ihrer hohen chemischen Spezifität 
nachfolgend diagnostische Information zu liefern. Der Vorteil in der Verwendung 
zweier Modalitäten besteht darin, mehr Informationen in einem diagnostischen 
Schritt zu extrahieren. Dies würde definitiv die mühsame Prozesskette, welche 
ansonsten für eine schnelle und erfolgreiche Diagnose erforderlich ist, reduzieren. 
Zudem wird es nicht nur für eine schnellere Diagnose sorgen, sondern auch die Zahl 
der Operationen reduzieren, was das Risiko von Infektionen verringert. Vor- und 
Nachteile des kombinierten Aufbaus sind in Tabelle 6.1 zusammengefasst. 
 
Table 6.1 Zusammenfassung der Vorteile und Nachteile eines kombinierten OCT-Raman-
Spektoskopie Systems.  
Anwendungsbereich  
in vivo 
OCT- Raman 
Vorteile  Nachteile 
Differenzierung von 
Nicht-Melanom-
Hautkrebs  
Sowohl morphologische als auch 
chemische Daten extrahierend 
Optische Bauteile müssen zu 
beiden Modalitäten passen 
Reduzierte Anzahl an 
Operationen durch die 
Eliminierung von Folgebiopsien 
Hohe Fluoreszenz überlagert das 
Raman-Signal 
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Fähig die Grenze zwischen 
krankem und gesundem Gewebe 
festzustellen 
Raman-Laserleistung muss 
reguliert werden 
Identifizierung von 
atherosklerotischen 
Plaque  
wie oben Kontrastmittel und 
Röntgenbildgebung notwendig 
Vulnerable Plaque von zwei 
Modalitäten bestätigt 
Invasiv 
Reduziertes Risiko von 
Infektionen 
 
 
Das OCT-Raman-Gerät zeigte eine ausreichende axiale und laterale Auflösung (OCT 
- 10µm und 13µm, Raman-Spektroskopie - 700 -1000µm und ~ 105µm), um das 
erkrankte Gewebe von dem Gesunden zu identifizieren. Die schwierigste Aufgabe 
während der Implementierung des Geräts war die Wahl der Objektivlinse. Eine 
Gesamtzahl von 5 Objektivlinsen wurde ausgiebig an einem Standard sowie einer 
kommerziell erhältlichen Schweinelenden-Probe getestet. Dies hat einen vorläufigen 
Überblick über die spektrale Qualität sowie das Ausmaß des fluoreszierenden 
Hintergrunds gegeben. Da die für diese Kombination ausgewählte Objektivlinse 
bereits einen Kompromiss darstellte, würde ein besserer Ersatz die spektrale Qualität 
weiter verbessern. Ein solcher würde es zudem ermöglichen, die notwendige 
Laserleistung zu reduzieren, welche die Akzeptanz einer solchen Vorrichtung in der 
medizinischen Industrie beeinflusst. Wenn das Gerät in Form einer Fasersonde 
miniaturisiert werden würde, wäre eine Objektivlinse nicht mehr notwendig. Diese 
Lösung wäre in beiden medizinischen Anwendungen vorteilhaft. 
 
Aus der Nicht-Melanom-Hautkrebs-Pilotstudie wurde wertvolles Wissen über die 
verschiedenen Hautkrebsarten gewonnen. Aufgrund der großen Anzahl von 
Basalzellkarzinomen (BCCs), die während der klinischen Studie auftraten, lag der 
Schwerpunkt der abschließenden Datenanalyse auf dieser speziellen Art von Tumor. 
Die OCT-B-Scans von BCC-Proben hatten eine signifikante Korrelation mit den H 
& E-gefärbten Gewebeschnitten gezeigt. Aufgrund von standardisierten 
Krankenhausverfahren ließen sich die OCT-Bilder nicht eins zu eins mit der 
Histopathologie korrelieren. Dies limitierte die Genauigkeit der Datenkorrelation. 
Jedoch konnte durch die mit Raman-Spektren gekoppelte OCT-
Querschnittsinformation mehr Information im Rahmen einer einzelnen Messung 
extrahiert werden. Ein paar der gemessenen SCC-Proben erzeugten größere 
Fluoreszenzsignale im Vergleich zu denen von BCCs, die die Extraktion von Raman-
Signalen behinderten. 
 
Eine häufige Einschränkung während der gesamten Experimente war das Fehlen einer 
großen Probenanzahl. Die für diese Studie verwertbare Patientenanzahl musste von 
18 auf 7 reduziert werden, da das System verändert wurde, um die 
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Sammlungseffizienz zu erhöhen. Dies verstärkte jedoch die Fluoreszenz, sodass 
jegliche Raman-Signale verdeckt wurden. Von den 7 Patienten, die für diese Studie 
in Betracht gezogen wurden, wurde ein Trend in der spektralen Form entdeckt, der 
innerhalb der 7 BCC-Proben übereinstimmte. Eine größere Probenanzahl wäre 
erforderlich, um ein erfolgreiches Klassifizierungsmodell sowie einen 
Trainingsdatensatz zur Vorhersage von Krebs- und Nichtkrebsregionen zu erstellen. 
Als ein zukünftiger Schritt könnte ein großer Datensatz dafür verwendet werden, um 
eine Datenbank zu bilden, die die Klassifizierung von Tumortypen am Patienten 
direkt unterstützt. Unter der Annahme einer großen Anzahl von Proben wäre ein 
PLS-LDA-Algorithmus zur Vorhersage der Tumorgrenzen im Gewebe geeignet. Dies 
würde eine sorgfältige Bewertung verschiedener Arten von BCC-Variationen 
erfordern. Um eine verringerte Fluoreszenz zu erreichen und somit das Rauschlevel 
zu reduzieren, wäre das Messen in einem höheren Wellenlängenbereich, wie 
beispielsweise 1064nm, vorteilhaft. Obwohl dies zu längeren Integrationszeiten führen 
würde, wäre eine klinische Anwendung mit einer Live-Diagnose-Funktion als 
zukünftige Implementierung noch immer möglich. Die Integration des Geräts in einen 
medizinischen Wagen ermöglichte eine hohe Mobilität in Kliniken. Die Verwendung 
von lichtundurchlässigem Material schirmte das Raman-System und den Sondenkopf  
vor Streulicht ab, was das Raman-Signal gestört hätte. Die Systemsoftware erfüllte 
alle Benutzeranforderungen, jedoch wären weitere Verbesserungen hinsichtlich der 
Benutzerfreundlichkeit erforderlich. Für zukünftige medizinische Anwendungen muss 
die Software überarbeitet und mit einem robusten Algorithmus gekoppelt werden, der 
die aktuelle Funktionalität erweitert, um die Diagnose zusammen mit einem 
Konfidenzintervall anzuzeigen. 
 
Die Bildgebung der atherosklerotische Plaques  mit dem kombinierten OCT-Raman-
System konzentrierte sich nur auf  ex vivo Proben. Obwohl ein erster Überblick über 
frühe Plaques von Tieraortas geliefert wurde, waren die fortgeschrittenen Plaques 
menschliche Proben. Da frühe Plaques keine Symptome zeigen und ein geringes 
Bruchrisiko aufweisen, gibt es nur wenige umfassende Untersuchungen an 
menschlichen proben. Im fortgeschrittenen Stadium werden invasive Maßnahmen 
empfohlen, um eine Stenose zu vermeiden. Aus der bestehenden Literatur kann ein 
gutes Verständnis hinsichtlich der Plaque-Diagnose mittels OCT gewonnen werden 
[40, 80, 82, 124]. Das Hauptmerkmal, das in dieser Studie beobachtet wurde, war die 
geringe OCT-Intensität, an Stellen wo Lipide oder Calcium vorhanden waren, im 
Vergleich zu nicht betroffenem Gewebe. Darüber hinaus schien das perfekt 
kreisförmige Lumen mit Schwellungen oder Abnutzung deformiert zu sein. Bei in vivo 
Untersuchungen atherosklerotischer Plaques hatten die mit OCT gewonnenen Bilder 
eine hohe Wahrscheinlichkeit, Bewegungsartefakte von Atmung und Herzschlag zu 
tragen. Um solche Verzerrungen zu überwinden, hat eine Forschungsgruppe in den 
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Niederlanden Koronararterien innerhalb eines Herzzyklus durch Implementierung 
einer schnellen OCT-Pullback-Methode gemessen [121]. Die Kombination einer 
solchen Technik mit der Raman-Spektroskopie würde eine vollständige Plaque-
Diagnose ermöglichen. Die Raman-Spektren der ex vivo Kaninchenproben zeigten 
einen Nachweis von Cholesterin (702, 1437 und 1661 cm-1), während menschliche ex 
vivo Proben keine Triglyceride, aber anderweitige Lipide (1442, 1660 und 2800 - 3000 
cm-1), Calcium (960 cm-1) und Protein (1455-1650 cm-1) aufwiesen. Das Interpretieren 
von Raman-Spektren von Aorten erforderte ein gründliches Verständnis der 
Plaquebildung auf molekularer Ebene. Um ein tieferes Verständnis der metabolischen 
Prozesse und der Speichermechanismen von Lipiden in Zellen zu erhalten, haben 
Stiebing et al. [125, 126] diese Prozesse durch zelluläre Inkubation untersucht. Auf 
makroskopischer Ebene sind diese molekularen Merkmale jedoch möglicherweise 
aufgrund der Komplexität von organischem Gewebe nicht vorhanden. Der Anteil der 
beobachteten Fluoreszenz war bei der Messung von koaguliertem Blut, das ebenfalls 
zur Überhitzung neigte, drastisch angestiegen. Daher würden sich für zukünftige 
Schritte frische Proben ohne Fixierung in Formalin empfehlen. Die  in vivo Messungen 
resultierten in der Charakterisierung früher Plaques, was die Eignung der Vorrichtung 
für diese spezielle Anwendung bewies. OCT und Raman-Spektroskopie bestätigten 
beide die Anwesenheit von Lipiden.  
 
Für die endgültige Anwendung des kombinierten Systems unter klinischen 
Bedingungen wäre eine OCT-Raman-Fasersonde wichtig, um in die Arterien zu 
gelangen. Die entwickelte OCT-Fasersonde hatte sehr klare B- und C-Scans erzeugt 
und entsprach den gewünschten Messparametern wie Arbeitsabstand, Form des 
Laserspots und Auflösung. Um jedoch zu bestätigen, dass diese OCT-Fasersonde für 
klinische Messungen geeignet ist, sollten mehr Proben mit unterschiedlichen Stadien 
der Plaques untersucht werden. Sobald die OCT-Raman-Fasersonde entwickelt ist, 
kann die Messstrategie weiter auf ihre Eignung für  in vivo Messungen charakterisiert 
werden. Mit einem Raman-freien Kontrastmittel kann der übliche Arbeitsablauf 
verfolgt werden, d.h. zuerst die Bildgebung mit OCT und dann die Messung 
betroffener Bereiche mit Raman-Spektroskopie, um den Plaquezu charakterisieren. 
Verglichen mit den derzeitigen Diagnoseverfahren sind schnellere und effizientere 
Wege wichtig, da die Atherosklerose ohne Symptome bis zu späten Stadien anhalten 
kann. Möglicherweise könnte die entwickelte Nadel-Sonde in der Hautkrebs-
Bildgebung ähnlich der zur Untersuchung von Brustkrebs [51] verwendet werden. 
Eine genauere Differenzierung der Krebsgrenzen in alle Richtungen könnte ermöglicht 
werden. Dies würde jedoch das nicht-invasive Kriterium verletzen. Aufgrund der 
Schwierigkeit und der Zurückhaltung, neue Technologien in den routinemäßigen 
diagnostischen Arbeitsablauf aufzunehmen, würde es einige Jahre dauern, bis sich ein 
großer Wandel in der medizinischen Industrie abzeichnet. Angesichts des gestiegenen 
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Interesses an Point-of-Care-Geräten [127] könnten die Aufsichtsbehörden die aktive 
Prüfung neuartiger medizinischer Geräte einschließen, um weitere Kenntnisse über 
Krankheiten zu erlangen und die Heilungschancen durch Früherkennung zu erhöhen. 
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